US20050059750A1 - Non-oxidizing polymeric medical implant - Google Patents
Non-oxidizing polymeric medical implant Download PDFInfo
- Publication number
- US20050059750A1 US20050059750A1 US10/935,510 US93551004A US2005059750A1 US 20050059750 A1 US20050059750 A1 US 20050059750A1 US 93551004 A US93551004 A US 93551004A US 2005059750 A1 US2005059750 A1 US 2005059750A1
- Authority
- US
- United States
- Prior art keywords
- polyethylene
- molecular weight
- air
- days
- oven aging
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- YAMXIEVGTCISKX-UHFFFAOYSA-N O=O.O=O.[PH][PH] Chemical compound O=O.O=O.[PH][PH] YAMXIEVGTCISKX-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
- A61L2/08—Radiation
- A61L2/081—Gamma radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/60—Liquid-swellable gel-forming materials, e.g. super-absorbents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
- A61L2/08—Radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
- A61L2/08—Radiation
- A61L2/082—X-rays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
- A61L2/08—Radiation
- A61L2/087—Particle radiation, e.g. electron-beam, alpha or beta radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/16—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/04—Macromolecular materials
- A61L29/041—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/048—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C35/00—Heating, cooling or curing, e.g. crosslinking or vulcanising; Apparatus therefor
- B29C35/02—Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould
- B29C35/08—Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould by wave energy or particle radiation
- B29C35/0805—Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould by wave energy or particle radiation using electromagnetic radiation
- B29C2035/085—Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould by wave energy or particle radiation using electromagnetic radiation using gamma-ray
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C35/00—Heating, cooling or curing, e.g. crosslinking or vulcanising; Apparatus therefor
- B29C35/02—Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould
- B29C35/08—Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould by wave energy or particle radiation
- B29C35/0805—Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould by wave energy or particle radiation using electromagnetic radiation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C43/00—Compression moulding, i.e. applying external pressure to flow the moulding material; Apparatus therefor
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C43/00—Compression moulding, i.e. applying external pressure to flow the moulding material; Apparatus therefor
- B29C43/02—Compression moulding, i.e. applying external pressure to flow the moulding material; Apparatus therefor of articles of definite length, i.e. discrete articles
- B29C43/16—Forging
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2023/00—Use of polyalkenes or derivatives thereof as moulding material
- B29K2023/04—Polymers of ethylene
- B29K2023/06—PE, i.e. polyethylene
- B29K2023/0658—PE, i.e. polyethylene characterised by its molecular weight
- B29K2023/0683—UHMWPE, i.e. ultra high molecular weight polyethylene
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2105/00—Condition, form or state of moulded material or of the material to be shaped
- B29K2105/25—Solid
- B29K2105/253—Preform
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2995/00—Properties of moulding materials, reinforcements, fillers, preformed parts or moulds
- B29K2995/0037—Other properties
- B29K2995/0087—Wear resistance
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2995/00—Properties of moulding materials, reinforcements, fillers, preformed parts or moulds
- B29K2995/0037—Other properties
- B29K2995/0089—Impact strength or toughness
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
- B29L2031/00—Other particular articles
- B29L2031/753—Medical equipment; Accessories therefor
- B29L2031/7532—Artificial members, protheses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S522/00—Synthetic resins or natural rubbers -- part of the class 520 series
- Y10S522/915—Synthetic resins or natural rubbers -- part of the class 520 series involving inert gas, steam, nitrogen gas, or carbon dioxide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S525/00—Synthetic resins or natural rubbers -- part of the class 520 series
- Y10S525/937—Utility as body contact e.g. implant, contact lens or I.U.D.
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S623/00—Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
- Y10S623/901—Method of manufacturing prosthetic device
Definitions
- This invention relates to medical implants formed of a polymeric material such as ultra-high molecular weight polyethylene, with superior oxidation resistance upon irradiation and a method for making the same.
- Ultra-high molecular weight polyethylene is widely used for articulation surfaces in artificial knee and hip replacements.
- Ultra-high molecular weight polyethylene has been defined as those linear polyethylenes which have a relative viscosity of 2.3 or greater at a solution concentration of 0.05% at 135° C. in decahydronaphthalene.
- the nominal weight—average molecular weight is at least 400,000 and up to 10,000,000 and usually from three to six million.
- the manufacturing process begins with the polymer being supplied as fine powder which is consolidated into various forms, such as rods and slabs, using ram extrusion or compression molding. Afterwards, the consolidated rods or slabs are machined into the final shape of the orthopedic implant components. Alternatively, the component can be produced by compression molding of the UHMWPE resin powder.
- gamma ray, x-ray or electron beam radiation has been utilized as a preferred means of sterilization. These types of radiation use a high energy beam to kill bacteria, viruses, or other microbial species contained in the packaged medical products, achieving the goal of product sterility.
- the high energy beam causes generation of free radicals in polymers during radiation. It has also been recognized that the amount of free radicals generated is dependent upon the radiation dose received by the polymers and that the distribution of free radicals in the polymeric implant depends upon the geometry of the component, the type of polymer, the dose rate, and the type of radiation beam.
- the generation of free radicals can be described by the following reaction (which uses polyolefin and gamma ray irradiation for illustration):
- reaction 7 the hydroperoxides (rOOH and POOH) formed in reactions 3 and 5 will slowly break down as shown in reaction 7 to initiate post-radiation degradation.
- Reactions 8 and 9 represent termination steps of free radicals to form ester or carbon-carbon cross-links.
- the extent of reaction 8 and 9 in relation to reactions 2 through 7 may vary.
- irradiated UHMWPE a value of 0.3 for the ratio of chain scission to cross-linking has been obtained, indicating that even though cross-linking is a dominant mechanism, a significant amount of chain scission occurs in irradiated polyethylene.
- the primary free radicals r. or secondary free radicals P. can only react with other neighboring free radicals to form carbon-carbon cross-links, according to reactions 10 through 12 below. If all the free radicals react through reactions 10 through 12, there will be no chain scission and there will be no molecular weight degradation. Furthermore, the extent of cross-linking is increased over the original polymer prior to irradiation. On the other hand, if not all the free radicals formed are combined through reactions 10, 11 and 12, then some free radicals will remain in the plastic component.
- UHMWPE powders being heated and compressed into a homogeneously melted crystallized morphology with no grain memory of the UHMWPE powder particles and with enhanced modulus and strength.
- U.S. Pat. No. 5,037,928 discloses a prescribed heating and cooling process for preparing a UHMWPE exhibiting a combination of properties including a creep resistance of less than 1% (under exposure to a temperature of 23° C. and a relative humidity of 50% for 24 hours under a compression of 1000 psi) without sacrificing tensile and flexural properties.
- Patent Application GB 2 180 815 A discloses a packaging method where a medical device which is sealed in a sterile bag, after radiation/sterilization, is hermetically sealed in a wrapping member of oxygen-impermeable material together with a deoxidizing agent for prevention of post-irradiation oxidation.
- U.S. Pat. No. 5,153,039 relates to a high density polyethylene article with oxygen barrier properties.
- U.S. Pat. No. 5,160,464 relates to a vacuum polymer irradiation process.
- the present invention relates to a method for providing a polymeric material, such as UHMWPE, with superior oxidation resistance upon irradiation.
- a polymeric material such as UHMWPE
- UHMWPE will be used as an example to describe the invention.
- all the theories and processes described hereafter should also apply to other polymeric materials such as polypropylene, high density polyethylene, polyester, nylon, polyurethane and poly(methylmethacrylate) unless otherwise stated.
- UHMWPE polymer is very stable and has very good resistance to aggressive media except for strong oxidizing acids.
- free radicals are formed which cause UHMWPE to become activated for chemical reactions and physical changes.
- Possible chemical reactions include reacting with oxygen, water, body fluids, and other chemical compounds while physical changes include density, crystallinity, color, and other physical properties.
- a new sterilization radiation process greatly reduces the adverse effects caused by a conventional radiation process.
- this new sterilization process does not employ stabilizers, antioxidants, or any other chemical compounds which may have potential adverse effects in biomedical or orthopedic applications.
- a polymeric orthopedic implant component to be sterilized by radiation does not contain oxidants, such as oxygen or water (or moisture), or free radicals. This may be accomplished by obtaining a raw material for the implant manufactured under a special process as described herein and forming a part of the invention.
- the finished polymeric orthopedic component is then sealed in an oxidant-free atmosphere.
- This oxidant-free atmosphere is maintained during radiation.
- the radiated polymeric component is then subjected to a heat treatment to cross-link all the free radicals within themselves. During this treatment, the condition of oxidant-free atmosphere is maintained.
- the irradiated, heat treated plastic component is now ready to use. Exposure to oxygen or moisture will not cause oxidation.
- the oxidation resistance to any oxidizing agent is similar to that of the unirradiated virgin polymer.
- a method for producing a polymeric medical implant including the steps of placing the polymeric resin in a sealed container and removing a substantial portion of the oxygen from the container. After a predetermined time, the container is repressurized with an inert gas such as nitrogen, argon, helium or neon. The resin is thereafter transferred to a forming device which normally melts and forms the resin in an oxygen reduced atmosphere to produce a polymeric raw material.
- the polymeric raw material such as UHMWPE is then machined to an implant such as a tibial tray or a liner for an acetabular cup. The finished part is then sealed into a package in an oxygen reduced atmosphere.
- the package is of an airtight nature to prevent oxygen or moisture from entering after the package is sealed.
- the then packaged implant is radiation sterilized and then heat treated for the predetermined time and temperature sufficient to form cross-links between free radicals of the neighboring polymeric chains. This prevents further oxidation once the implant is removed from the package.
- the implant is heated for at least 48 hours at a temperature of about 37° C. to about 70° C. and preferably for 144 hours at 50° C.
- a raw polymeric material such as UHMWPE is obtained by, for example, ram extrusion, compression molding, or other forming processes. These methods use virgin polymer powder as a starting material.
- virgin polymer resin powder may contain air or moisture, which may exist in the resin micro-structure or simply deposited on the resin surfaces. If air or moisture is not removed from resin powder prior to the forming process, it can be trapped in the plastic matrix after forming and cannot escape. This is true even with the use of vacuum or gas flushing techniques. During the sterilization radiation process, the trapped air or moisture or both will react with free radicals generated in the plastic to cause oxidation. The trapped moisture can also absorb radiation energy and dissociate into oxygen and hydroxyl free radicals which will also react with the plastic to cause oxidation. Therefore, by removing air and moisture prior to the forming process, oxidation during sterilization radiation can be avoided.
- the preferred method for eliminating air and moisture is to apply a vacuum of less than 3′′ of mercury (76 torr) to the polymer resin for a prescribed time to reduce the levels of air and moisture to a minimal or acceptable value.
- the level for oxygen is preferably 0.5% (volume by volume and no more than 1%).
- the moisture level is preferably 10% of relative humidity (and no more than 20% relative humidity).
- sufficient amounts of deoxidizing agents, such as oxygen absorbents and moisture desiccants are placed together with the polymer resin in a sealed container to reduce the levels of air and moisture to the minimal or acceptable value.
- An example of an oxygen absorbent is AGELESS® which is an iron oxide compound and commercially available from Cryovac Division, W. R. Grace & Co., Duncan, S.C.
- moisture desiccant is silica gel which is commercially available. These materials are placed with the resin in the sealed container for approximately 10 hours. Alternately, or in combination, an inert gas, such as nitrogen, argon, helium or neon is used to flush the container, holding the polymer resin powder, until the levels of air and moisture are reduced to the accepted value. Of course, any combination of the above methods can also be used.
- an inert gas such as nitrogen, argon, helium or neon is used to flush the container, holding the polymer resin powder, until the levels of air and moisture are reduced to the accepted value.
- nitrogen, argon, helium or neon is used to flush the container, holding the polymer resin powder, until the levels of air and moisture are reduced to the accepted value.
- any combination of the above methods can also be used.
- the entire forming operation of, for example, ram extrusion, compression molding, or other forming process should be carried out in an inert or low oxygen atmosphere as well.
- UHMWPE polymer chains may be broken to generate free radicals and cross-links. While cross-links generated in the forming process have no adverse effects on material properties, the free radicals produced, as described above, can react with air or other oxidants. Therefore, it is important to maintain the inert atmosphere during the forming process to minimize oxidation.
- any free radicals generated should be eliminated as soon as the forming process is completed by annealing. If the formed UHMWPE contains free radicals and is exposed to air or other oxidants after the forming process, oxidation will occur.
- an elevated temperature Compared to room temperature, an elevated temperature not only increases the reaction rate constants, k 1 and k 2 , but also helps free radicals r ⁇ and P. to migrate in the plastic matrix to meet other neighboring free radicals for cross-linking reactions.
- the desired elevated temperature is between the room temperature and the melting point of the polymer.
- this temperature range is between about 25° C. and about 140° C.
- the preferred annealing temperature range is from about 37° C. to about 135° C.
- the preferred time and temperature is 130° C. for 20 hours with the minimum annealing time being about 4 hours (requiring a temperature at the high end of the range). It is to be noted that the higher the temperature used, the shorter the time period needed to combine free radicals.
- the formed UHMWPE often contains residual (internal) stress caused by incomplete relaxation during the cooling process, which is the last step of the forming process.
- the annealing process described herein will also help to eliminate or reduce the residual stress.
- a residual stress contained in a plastic matrix can cause dimensional instability and is in general undesirable.
- the formed UHMWPE is further machined into desired shapes.
- the machining is done at room temperature and no damage to the plastic will occur.
- certain machine tools when operated at a high speed, may generate local heat and cause thermal breakdown of UHMWPE polymer chains.
- the above described annealing process may be employed to eliminate any newly formed free radicals prior to packaging.
- the polymeric component After machining, the polymeric component is packaged in an air tight package in an oxidant-free atmosphere. Thus, all air and moisture must be removed from the package prior to the sealing step. Machines to accomplish this are commercially available, such as from Orics Industries Inc., College Point, N.Y., which flush the package with a chosen inert gas, vacuum the container, flush the container for the second time, and then heat seal the container with a lid. In general, less than 0.5% (volume by volume) oxygen concentration can be obtained consistently.
- An example of a suitable oxidant impermeable (air tight) packaging material is polyethylene terephthalate (PET).
- oxidant impermeable packaging material is poly(ethylene vinyl alcohol) and aluminum foil, whose oxygen and water vapor transmission rates are essentially zero. All these materials are commercially available.
- suitable commercial packaging materials utilize a layer structure to form a composite material with superior oxygen and moisture barrier properties.
- An example of this type is a layered composite comprised of polypropylene/poly(ethylene vinyl alcohol)/polypropylene.
- the sterilization radiation step for the packaged implant may take a few hours to complete. As described above, it is imperative that during this time period, the transmission of oxidants, such as oxygen and moisture, into the package be kept to a minimal or at an acceptable value to avoid oxidation.
- A is a reaction dependent constant
- T absolute temperature (K)
- the temperature should not exceed the distortion temperature of either the packaging material or the plastic components.
- the temperature range is between about 25° C. and about 140° C.
- the preferred temperature is 37° C. to 70° C.
- the irradiated packaged plastic component After heat treatment, the irradiated packaged plastic component is now ready to use.
- the package can be opened and exposed to air or moisture without causing oxidation.
- the oxidation resistance of the sterilized plastic component to other oxidants is similar to that of the virgin, unirradiated polymer.
- a surgical grade UHMWPE rod produced by ram extrusion was machined into samples of desirable shapes. Four sets of samples were prepared using these machined samples by the following methods:
- Method A a UHMWPE sample as machined and unirradiated.
- Method B A UHMWPE sample was heat sealed in a glycol-modified polyethylene terephthalate (PETG, made by Eastman Plastics, Inc., Kingsport, Tenn.) blister in air with an aluminum lid of 0.1 mm in thickness.
- PETG polyethylene terephthalate
- the sealed blister containing the UHMWPE sheet was sterilized by irradiation of gamma-rays in a dose of 2.5 Mrad. The package was then opened and exposed to room air.
- Method C A UHMWPE sample was placed in a PETG blister and heat sealed in dry nitrogen with an aluminum lid of 0.1 mm in thickness by the Orics Vacuum Gas Flush Heat Seal Machine (Model SLS-VGF-100M for modified atmosphere packaging, made by Orics Industries Inc., College Point, N.Y.) which went through the following cycles:
- the oxygen concentration in the sealed blister was measured by a Mocon Oxygen Analyzer to be 0.325% (volume by volume).
- the sealed blister containing the UHMWPE sample was sterilized by irradiation of gamma-rays in a dose of 2.5 Mrad.
- the oxygen concentration in the sealed blister after sterilization radiation was measured to be 0.350%.
- the package was then opened and exposed to room air.
- Method D Same as Method C, except that after gamma-ray irradiation, the sealed blister containing the UHMWPE sample was heat treated at 50° C. for 144 hours in an oven, then transferred from the oven to room temperature for cooling. After the package was cooled to room temperature, the oxygen concentration was measured by a Mocon Oxygen Analyzer to be 0.360%. The package was then opened and exposed to room air.
- the peak area is proportional to the amount of oxidized UHMWPE in the specimen.
- the integrated peak area was then normalized to the specimen thickness, by dividing by the area of the 1463 cm ⁇ 1 (methyl) peak which is proportional to the specimen thickness. The obtained ratio was defined as oxidation index.
- Tensile breaking strength results are shown in Table 2: TABLE 2 Tensile Breaking Sample Strength, psi Method B/not oven aged 6510 Method B/11 day oven aging 5227 Method B/23 day oven aging 3192 Method C/not oven aged 6875 Method C/11 day oven aging 6400 Method C/23 day oven aging 6004 Method D/not oven aged 6941 Method D/11 day oven aging 7113 Method D/23 day oven aging 6904
- tensile breaking strength shows the most deterioration for the sample irradiated in air (Method B).
- the sample irradiated in nitrogen (Method C) shows some improvement over the sample prepared by Method B.
- the decrease in tensile breaking strength upon oven aging still occurs.
- the sample irradiated in nitrogen followed by heat treatment shows no change in tensile breaking strength, indicating a superior oxidation resistance.
- the column Prior to sample runs, the column was calibrated using narrow MW polystyrene standards. Since the samples were only partially soluble in the solvent due to cross-linking, the so-determined molecular weight distribution was for the soluble portion only.
- the filters were cooled to room temperature and washed individually with dichloromethane. They were then placed in a convection oven at 105° C. for 6 hours to dry and then reweighed. The weight fraction of the undissolved (cross-linked) portion was then determined based upon the initial weight of 200 mg. To determine the low molecular weight fraction present in each sample, the weight fraction of molecular weight below 10 5 in the soluble portion, determined by GPC, was multiplied by the percent solubility to give weight percent of low molecular weight fraction in each sample.
- the sample made by Method D contains more cross-linking (i.e., less soluble) than one made by Method B.
- the low molecular weight fraction (defined as below 10 5 ) in the sample made by Method B increases from 0.275 to 0.481 while that of the sample made by Method D remains virtually unchanged at about 0.18 after 23 days of oven aging.
- the increase in low molecular weight fraction was due to chain scission caused by oxidative reactions.
- the results indicate that the process of method D can produce an irradiated polymer with a superior oxidation resistance.
- Results are shown in Table 5: TABLE 5 TYS, TBS, Toughness, Sample EAB, % psi psi lbs-in/in 3 Air 414 3547 6257 10,210 annealed Nitrogen 485 3517 8917 18,960 annealed Note: EAB—elongation at break TYS—tensile yield strength TBS—Tensile breaking strength
- the sample annealed in nitrogen exhibits a higher elongation at break, a higher tensile breaking strength, and a higher toughness, compared to one annealed in air, while the tensile yield strength is similar between the two samples.
- the results indicate that the sample annealed in nitrogen is more ductile than the one annealed in air.
- the loss of ductility in the sample annealed in air is due to oxidative chain scission.
Abstract
A medical implant made of polymeric material having an increased oxidation resistance is formed by a method including the steps of placing a resin powder in a sealed container. A substantial portion of the oxygen is removed from the sealed contained by either a vacuum, an oxygen absorbent or by flushing with inert gas. The container is then repressurized with a gas such as nitrogen, argon, helium or neon so that long term storage may be possible. On use, the resin in transferred to a forming device which both melts and forms the resin in an oxygen reduced atmosphere to produce a polymeric raw material such as a rod or bar stock. The medical implant is then formed from this raw material annealed and sealed in an airtight package in an oxygen reduced atmosphere. The implant is then radiation sterilized and thereafter annealed in the package for a predetermined time and temperature sufficient to form cross-links between any free radicals in neighboring polymeric chains.
Description
- This application is a divisional of U.S. Ser. No. 10/461,636 filed Jun. 13, 2003 which is a continuation of U.S. Ser. No. 10/041,118 filed Jan. 8, 2002 which is a continuation of U.S. Pat. No. 6,372,814 which is a continuation of U.S. Pat. No. 6,174,934, which is a continuation of U.S. Ser. No. 733,067 filed Oct. 16, 1996, U.S. Pat. No. 5,728,748, which is a continuation of U.S. Ser. No. 439,028 filed May 11, 1995, U.S. Pat. No. 5,650,485, which is a division of U.S. Ser. No. 320,705 filed Oct. 7, 1994, U.S. Pat. No. 5,449,745 which is a division of U.S. Ser. No. 08/070,074 filed Jun. 1, 1993, U.S. Pat. No. 5,414,049.
- This invention relates to medical implants formed of a polymeric material such as ultra-high molecular weight polyethylene, with superior oxidation resistance upon irradiation and a method for making the same.
- Various polymer systems have been used for the preparation of artificial prostheses for biomedical use, particularly orthopedic applications. Among them, ultra-high molecular weight polyethylene is widely used for articulation surfaces in artificial knee and hip replacements. Ultra-high molecular weight polyethylene (UHMWPE) has been defined as those linear polyethylenes which have a relative viscosity of 2.3 or greater at a solution concentration of 0.05% at 135° C. in decahydronaphthalene. The nominal weight—average molecular weight is at least 400,000 and up to 10,000,000 and usually from three to six million. The manufacturing process begins with the polymer being supplied as fine powder which is consolidated into various forms, such as rods and slabs, using ram extrusion or compression molding. Afterwards, the consolidated rods or slabs are machined into the final shape of the orthopedic implant components. Alternatively, the component can be produced by compression molding of the UHMWPE resin powder.
- All components must then go through a sterilization procedure prior to use, but usually after being packaged. There exists several sterilization methods which can be utilized for medical applications, such as the use of ethylene oxide, heat, or radiation. However, applying heat to a packaged polymeric medical product can destroy either the integrity of the packaging material (particularly the seal, which prevents bacteria from going into the package after the sterilization step) or the product itself.
- Because ethylene oxide may adversely impact environmental and employee safety, gamma ray, x-ray or electron beam radiation has been utilized as a preferred means of sterilization. These types of radiation use a high energy beam to kill bacteria, viruses, or other microbial species contained in the packaged medical products, achieving the goal of product sterility.
- However, it has been recognized that regardless of the radiation type, the high energy beam causes generation of free radicals in polymers during radiation. It has also been recognized that the amount of free radicals generated is dependent upon the radiation dose received by the polymers and that the distribution of free radicals in the polymeric implant depends upon the geometry of the component, the type of polymer, the dose rate, and the type of radiation beam. The generation of free radicals can be described by the following reaction (which uses polyolefin and gamma ray irradiation for illustration):
- Depending whether or not oxygen is present, primary free radicals r˜ will react with oxygen and the polymer according to the following reactions as described in “Radiation Effects on Polymers”, edited by Roger L. Clough and Shalaby W. Shalaby, published by American Chemical Society, Washington, D.C., 1991.
-
- In radiation in air, primary free radicals r. will react with oxygen to form peroxyl free radicals r02., which then react with polyolefin (such as UHMWPE) to start the oxidative chain scission reactions (reactions 2 through 6). Through these reactions, material properties of the plastic, such as molecular weight, tensile, and wear properties, are degraded.
- Recently, it was found that the hydroperoxides (rOOH and POOH) formed in reactions 3 and 5 will slowly break down as shown in reaction 7 to initiate post-radiation degradation. Reactions 8 and 9 represent termination steps of free radicals to form ester or carbon-carbon cross-links. Depending on the type of polymer, the extent of reaction 8 and 9 in relation to reactions 2 through 7 may vary. For irradiated UHMWPE, a value of 0.3 for the ratio of chain scission to cross-linking has been obtained, indicating that even though cross-linking is a dominant mechanism, a significant amount of chain scission occurs in irradiated polyethylene.
- By applying radiation in an inert atmosphere, since there is no oxidant present, the primary free radicals r. or secondary free radicals P. can only react with other neighboring free radicals to form carbon-carbon cross-links, according to reactions 10 through 12 below. If all the free radicals react through reactions 10 through 12, there will be no chain scission and there will be no molecular weight degradation. Furthermore, the extent of cross-linking is increased over the original polymer prior to irradiation. On the other hand, if not all the free radicals formed are combined through reactions 10, 11 and 12, then some free radicals will remain in the plastic component.
- In an Inert Atmosphere
r.+polyolefin - - - P. (10)
2 r. - - - r-r (C—C cross-linking) (11)
2 P. - - - P—P (C—C cross-linking) (12) - It is recognized that the fewer the free radicals, the better the polymer retains its physical properties over time. The greater the number of free radicals, the greater the degree of molecular weight and polymer property degradation will occur. Applicant has discovered that the extent of completion of free radical cross-linking reactions is dependent on the reaction rates and the time period given for reaction to occur.
- Several prior art patents attempt to provide methods which enhance UHMWPE physical properties. European Patent Application 0 177 522 81 discloses UHMWPE powders being heated and compressed into a homogeneously melted crystallized morphology with no grain memory of the UHMWPE powder particles and with enhanced modulus and strength. U.S. Pat. No. 5,037,928 discloses a prescribed heating and cooling process for preparing a UHMWPE exhibiting a combination of properties including a creep resistance of less than 1% (under exposure to a temperature of 23° C. and a relative humidity of 50% for 24 hours under a compression of 1000 psi) without sacrificing tensile and flexural properties. U.K. Patent Application GB 2 180 815 A discloses a packaging method where a medical device which is sealed in a sterile bag, after radiation/sterilization, is hermetically sealed in a wrapping member of oxygen-impermeable material together with a deoxidizing agent for prevention of post-irradiation oxidation.
- U.S. Pat. No. 5,153,039 relates to a high density polyethylene article with oxygen barrier properties. U.S. Pat. No. 5,160,464 relates to a vacuum polymer irradiation process.
- The present invention relates to a method for providing a polymeric material, such as UHMWPE, with superior oxidation resistance upon irradiation. For the purpose of illustration, UHMWPE will be used as an example to describe the invention. However, all the theories and processes described hereafter should also apply to other polymeric materials such as polypropylene, high density polyethylene, polyester, nylon, polyurethane and poly(methylmethacrylate) unless otherwise stated.
- As stated above, while UHMWPE polymer is very stable and has very good resistance to aggressive media except for strong oxidizing acids. Upon sterilization radiation, free radicals are formed which cause UHMWPE to become activated for chemical reactions and physical changes. Possible chemical reactions include reacting with oxygen, water, body fluids, and other chemical compounds while physical changes include density, crystallinity, color, and other physical properties. In the present invention a new sterilization radiation process greatly reduces the adverse effects caused by a conventional radiation process. Furthermore, this new sterilization process does not employ stabilizers, antioxidants, or any other chemical compounds which may have potential adverse effects in biomedical or orthopedic applications.
- In the sterilization process of the present invention, a polymeric orthopedic implant component to be sterilized by radiation does not contain oxidants, such as oxygen or water (or moisture), or free radicals. This may be accomplished by obtaining a raw material for the implant manufactured under a special process as described herein and forming a part of the invention.
- The finished polymeric orthopedic component is then sealed in an oxidant-free atmosphere. This oxidant-free atmosphere is maintained during radiation. The radiated polymeric component is then subjected to a heat treatment to cross-link all the free radicals within themselves. During this treatment, the condition of oxidant-free atmosphere is maintained. The irradiated, heat treated plastic component is now ready to use. Exposure to oxygen or moisture will not cause oxidation. The oxidation resistance to any oxidizing agent is similar to that of the unirradiated virgin polymer.
- It is therefore an object of the invention to provide a polymeric orthopedic implant having superior oxidation resistance after irradiation.
- It is still another object of the invention to provide a method for manufacturing such an implant from the resin powder thereof through the final sterilization step so that the implant may thereafter be exposed to air without degradation due to oxidation.
- These and other objects are achieved by a method for producing a polymeric medical implant including the steps of placing the polymeric resin in a sealed container and removing a substantial portion of the oxygen from the container. After a predetermined time, the container is repressurized with an inert gas such as nitrogen, argon, helium or neon. The resin is thereafter transferred to a forming device which normally melts and forms the resin in an oxygen reduced atmosphere to produce a polymeric raw material. The polymeric raw material, such as UHMWPE is then machined to an implant such as a tibial tray or a liner for an acetabular cup. The finished part is then sealed into a package in an oxygen reduced atmosphere. The package is of an airtight nature to prevent oxygen or moisture from entering after the package is sealed. The then packaged implant is radiation sterilized and then heat treated for the predetermined time and temperature sufficient to form cross-links between free radicals of the neighboring polymeric chains. This prevents further oxidation once the implant is removed from the package.
- In general, the implant is heated for at least 48 hours at a temperature of about 37° C. to about 70° C. and preferably for 144 hours at 50° C.
- In the preferred method, a raw polymeric material such as UHMWPE is obtained by, for example, ram extrusion, compression molding, or other forming processes. These methods use virgin polymer powder as a starting material.
- However, virgin polymer resin powder may contain air or moisture, which may exist in the resin micro-structure or simply deposited on the resin surfaces. If air or moisture is not removed from resin powder prior to the forming process, it can be trapped in the plastic matrix after forming and cannot escape. This is true even with the use of vacuum or gas flushing techniques. During the sterilization radiation process, the trapped air or moisture or both will react with free radicals generated in the plastic to cause oxidation. The trapped moisture can also absorb radiation energy and dissociate into oxygen and hydroxyl free radicals which will also react with the plastic to cause oxidation. Therefore, by removing air and moisture prior to the forming process, oxidation during sterilization radiation can be avoided.
- The preferred method for eliminating air and moisture is to apply a vacuum of less than 3″ of mercury (76 torr) to the polymer resin for a prescribed time to reduce the levels of air and moisture to a minimal or acceptable value. The level for oxygen is preferably 0.5% (volume by volume and no more than 1%). The moisture level is preferably 10% of relative humidity (and no more than 20% relative humidity). Then sufficient amounts of deoxidizing agents, such as oxygen absorbents and moisture desiccants, are placed together with the polymer resin in a sealed container to reduce the levels of air and moisture to the minimal or acceptable value. An example of an oxygen absorbent is AGELESS® which is an iron oxide compound and commercially available from Cryovac Division, W. R. Grace & Co., Duncan, S.C. An example of moisture desiccant is silica gel which is commercially available. These materials are placed with the resin in the sealed container for approximately 10 hours. Alternately, or in combination, an inert gas, such as nitrogen, argon, helium or neon is used to flush the container, holding the polymer resin powder, until the levels of air and moisture are reduced to the accepted value. Of course, any combination of the above methods can also be used.
- In order to ensure a raw material for an orthopedic implant with no oxygen, not only must the UHMWPE resin powder be free of air and moisture, but the entire forming operation of, for example, ram extrusion, compression molding, or other forming process should be carried out in an inert or low oxygen atmosphere as well. During the forming process, due to high temperature and high pressure applied in the process, UHMWPE polymer chains may be broken to generate free radicals and cross-links. While cross-links generated in the forming process have no adverse effects on material properties, the free radicals produced, as described above, can react with air or other oxidants. Therefore, it is important to maintain the inert atmosphere during the forming process to minimize oxidation.
- Any free radicals generated should be eliminated as soon as the forming process is completed by annealing. If the formed UHMWPE contains free radicals and is exposed to air or other oxidants after the forming process, oxidation will occur. The polymer should be annealed at an elevated temperature in an inert atmosphere for a prescribed time. This is because the rate of free radical reactions (reactions 10 through 12) increases with increasing temperature, according to the following general expressions:
- Compared to room temperature, an elevated temperature not only increases the reaction rate constants, k1 and k2, but also helps free radicals r˜and P. to migrate in the plastic matrix to meet other neighboring free radicals for cross-linking reactions. In general, the desired elevated temperature is between the room temperature and the melting point of the polymer. For UHMWPE, this temperature range is between about 25° C. and about 140° C. However, the preferred annealing temperature range is from about 37° C. to about 135° C. The preferred time and temperature is 130° C. for 20 hours with the minimum annealing time being about 4 hours (requiring a temperature at the high end of the range). It is to be noted that the higher the temperature used, the shorter the time period needed to combine free radicals. Additionally, due to the high viscosity of a UHMWPE melt, the formed UHMWPE often contains residual (internal) stress caused by incomplete relaxation during the cooling process, which is the last step of the forming process. The annealing process described herein will also help to eliminate or reduce the residual stress. A residual stress contained in a plastic matrix can cause dimensional instability and is in general undesirable.
- In applications such as for orthopedic implants, the formed UHMWPE is further machined into desired shapes. In general, the machining is done at room temperature and no damage to the plastic will occur. However, certain machine tools, when operated at a high speed, may generate local heat and cause thermal breakdown of UHMWPE polymer chains. In this case, the above described annealing process may be employed to eliminate any newly formed free radicals prior to packaging.
- After machining, the polymeric component is packaged in an air tight package in an oxidant-free atmosphere. Thus, all air and moisture must be removed from the package prior to the sealing step. Machines to accomplish this are commercially available, such as from Orics Industries Inc., College Point, N.Y., which flush the package with a chosen inert gas, vacuum the container, flush the container for the second time, and then heat seal the container with a lid. In general, less than 0.5% (volume by volume) oxygen concentration can be obtained consistently. An example of a suitable oxidant impermeable (air tight) packaging material is polyethylene terephthalate (PET). Other examples of oxidant impermeable packaging material is poly(ethylene vinyl alcohol) and aluminum foil, whose oxygen and water vapor transmission rates are essentially zero. All these materials are commercially available. Several other suitable commercial packaging materials utilize a layer structure to form a composite material with superior oxygen and moisture barrier properties. An example of this type is a layered composite comprised of polypropylene/poly(ethylene vinyl alcohol)/polypropylene.
- In general, the sterilization radiation step for the packaged implant may take a few hours to complete. As described above, it is imperative that during this time period, the transmission of oxidants, such as oxygen and moisture, into the package be kept to a minimal or at an acceptable value to avoid oxidation.
- Following sterilization radiation, a heat treatment step should be performed in an inert atmosphere and at an elevated temperature to cause free radicals to form cross-links without oxidation. If proper packaging materials and processes are used and oxidant transmission rates are minimal, then the oxidant-free atmosphere can be maintained in the package and a regular oven with air circulation can be used for heat treatment after sterilization. To absolutely ensure that no oxidants leak into the package, the oven may be operated under a vacuum or purged with an inert gas. In general, if a higher temperature is used, a shorter time period is required to achieve a prescribed level of oxidation resistance and cross-linking. In many cases, the relationship between the reaction temperature and the reaction rate follows the well-known Arrhennius equation:
k 1 or k2 =A* exp (−▴H/T) (14)
where k1 and k2 are reaction rate constants from reactions 13 and 14 - A is a reaction dependent constant
- ▴H is activation energy of reaction
- T is absolute temperature (K)
- However, the temperature should not exceed the distortion temperature of either the packaging material or the plastic components. For UHMWPE, the temperature range is between about 25° C. and about 140° C. However, considering the distortion of the packaging material, the preferred temperature is 37° C. to 70° C.
- It is very important to ensure that the number of free radicals has been reduced to a minimal or an accepted level by the heat treatment. This is because the presence of an oxidant causes not only the oxidation of pre-existing free radicals, but also the formation of new free radicals via reactions 2 through 7. When the number of free radicals grows, the extent of oxidation and the oxidation rate will increase according to the following equations:
- Where free radicals r. and P. can grow in number in the presence of oxidants and in turn increase the oxidation rates. It is also to be noted that the oxidation reaction rate constants k3 and k4 increase with increasing temperature, similar to k1 and k2. Therefore, to determine if a certain level of residual free radicals is acceptable or not, it is required to evaluate specific material properties after the plastic sample is stored or aged at the application temperature for a time period which is equal to or longer than the time period intended for the application of the plastic component. An alternative to the method to assess the aging effect is to raise the aging temperature of the plastic sample for a shorter time period. This will increase the reaction rate constants k3 and k4 significantly and shorten the aging time. It has been found that an acceptable level of residual free radicals is 1.0×1017g for UHMWPE use for orthopedic implants.
- After heat treatment, the irradiated packaged plastic component is now ready to use. The package can be opened and exposed to air or moisture without causing oxidation. The oxidation resistance of the sterilized plastic component to other oxidants is similar to that of the virgin, unirradiated polymer.
- Sample Preparation
- A surgical grade UHMWPE rod produced by ram extrusion was machined into samples of desirable shapes. Four sets of samples were prepared using these machined samples by the following methods:
- Method A: a UHMWPE sample as machined and unirradiated.
- Method B: A UHMWPE sample was heat sealed in a glycol-modified polyethylene terephthalate (PETG, made by Eastman Plastics, Inc., Kingsport, Tenn.) blister in air with an aluminum lid of 0.1 mm in thickness. The sealed blister containing the UHMWPE sheet was sterilized by irradiation of gamma-rays in a dose of 2.5 Mrad. The package was then opened and exposed to room air.
- Method C: A UHMWPE sample was placed in a PETG blister and heat sealed in dry nitrogen with an aluminum lid of 0.1 mm in thickness by the Orics Vacuum Gas Flush Heat Seal Machine (Model SLS-VGF-100M for modified atmosphere packaging, made by Orics Industries Inc., College Point, N.Y.) which went through the following cycles:
-
- i) nitrogen gas (moisture-free) flush for five seconds
- ii) vacuum to a pressure of equal to or below 3 inches of mercury
- iii) nitrogen gas flush (moisture-free) for five seconds
- iv) heat seal
- The oxygen concentration in the sealed blister was measured by a Mocon Oxygen Analyzer to be 0.325% (volume by volume). The sealed blister containing the UHMWPE sample was sterilized by irradiation of gamma-rays in a dose of 2.5 Mrad. The oxygen concentration in the sealed blister after sterilization radiation was measured to be 0.350%. The package was then opened and exposed to room air.
- Method D: Same as Method C, except that after gamma-ray irradiation, the sealed blister containing the UHMWPE sample was heat treated at 50° C. for 144 hours in an oven, then transferred from the oven to room temperature for cooling. After the package was cooled to room temperature, the oxygen concentration was measured by a Mocon Oxygen Analyzer to be 0.360%. The package was then opened and exposed to room air.
- Samples prepared by the above methods were used in the following examples for evaluation.
- Two sets of 1-mm-thick UHMWPE sheets prepared by Methods A through D above were oven aged in air at 80° C. for 11 and 23 days respectively. After these sheets were cooled in room temperature, a thin film specimen of about 100 microns in thickness was cut from each of the 1-mm-thick aged UHMWPE sheets and placed in an IR window for a standard FTIR (A Nicolet 710 FTIR system was used) transmission run. A total of 32 spectra (scans) was collected and averaged. To determine the extent of oxidation, the IR absorption peaks in the frequency range of between 1660 and 1800 cm−1, corresponding to carbonyl (C—O) functional groups, were integrated for the peak area. The peak area is proportional to the amount of oxidized UHMWPE in the specimen. To correct for difference in specimen thickness, the integrated peak area was then normalized to the specimen thickness, by dividing by the area of the 1463 cm−1 (methyl) peak which is proportional to the specimen thickness. The obtained ratio was defined as oxidation index. A third set of 1-mm-thick UHMWPE sheets prepared by methods A through D, but without oven aging, was also evaluated by the same FTIR method for comparison. Oxidation indices obtained are shown in Table 1:
TABLE 1 Sample Oxidation Index Method A/not oven aged ca. 0. Method A/11 day oven aging ca. 0. Method A/23 day oven aging ca. 0. Method B/not oven aged 0.02 Method B/11 day oven aging 0.06 Method B/23 day oven aging 0.11 Method C/not oven aged 0.01 Method C/11 day oven aging 0.04 Method C/23 day oven aging 0.08 Method D/not oven aged 0.01 Method D/11 day oven aging 0.01 Method D/23 day oven aging 0.01 - From Table 1 results, it can be seen that the unirradiated UHMWPE sample (Method A) was free of oxidation (below the ETIR detectable level), even after 23 days of oven aging in air at 80° C. On the other hand, the UHMWPE sample irradiated in air (Method B) showed considerable oxidation and the extent of oxidation (as indicated by the oxidation index) increased with increasing aging time. After 23 days of oven aging, the oxidation index reached 0.11. For the UHMWPE sample irradiated in nitrogen (Method C), the initial oxidation index before oven aging was 0.01 which was not significant. However, during the oven aging, the oxidation index increased to 0.04 for 11 days and 0.08 for 23 days respectively. The results indicate that while irradiation in an inert atmosphere is an improvement over oxidation in air, the irradiated plastic component will oxidize further over time once it is exposed to air or other oxidants. In contrast, the UHMWPE sample irradiated in nitrogen followed by heat treatment at 50° C. for 144 hours (Method D), showed an initial oxidation index of only 0.01 which did not increase after 11 or 23 days of oven aging, indicating that this sample has superior oxidation resistance than the samples prepared by Method B or C.
- Two sets of 1-mm-thick UHMWPE sheets prepared by Methods B through D cited in the Sample Preparation were oven aged in air at 80° C. for 11 and 23 days respectively. After these sheets were cooled in room temperature, six tensile specimens with a dumbbell shape according to ASTM D638 (Type IV) were cut from each of the 1-mm-thick aged UHMWPE sheets. A standard tensile test was performed for each specimen at a speed of 2 inches/mm. Another set of 1-mm-thick UHMWPE sheets prepared by Methods B through D cited in the Sample Preparation, but without oven aging, were also evaluated by the same tensile test method for comparison. Tensile breaking strength results (average of six tests for each condition) are shown in Table 2:
TABLE 2 Tensile Breaking Sample Strength, psi Method B/not oven aged 6510 Method B/11 day oven aging 5227 Method B/23 day oven aging 3192 Method C/not oven aged 6875 Method C/11 day oven aging 6400 Method C/23 day oven aging 6004 Method D/not oven aged 6941 Method D/11 day oven aging 7113 Method D/23 day oven aging 6904 - From Table 2, tensile breaking strength shows the most deterioration for the sample irradiated in air (Method B). The sample irradiated in nitrogen (Method C) shows some improvement over the sample prepared by Method B. However, the decrease in tensile breaking strength upon oven aging still occurs. In contrast, the sample irradiated in nitrogen followed by heat treatment (50° C. for 144 hours, Method D), shows no change in tensile breaking strength, indicating a superior oxidation resistance.
- Two sets of 1-mm-thick UHMWPE sheets prepared by Methods B and Method D cited in the Sample Preparation were oven aged in air at 80° C. for 11 and 23 days respectively. After these sheets were cooled in room temperature, samples cut from sheets were characterized by a high temperature gel permeation chromatograph (GPC) column for molecular weight distribution. The samples were dissolved in hot trichlorobenzene (TCB). They were then run in the aforementioned solvent at 1.2 ml/mm. using a Jordi Gel Mixed Bed Column, 50 cm×10.0 mm ID., at a column oven temperature of 145° C. on the Waters 15° C. Chromatograph. The injection size was 250 uL of a 0.1% solution. An antioxidant (N-phenyl-2-naphthylamine) was added to all high temperature GPC samples to prevent polymer deterioration.
- Prior to sample runs, the column was calibrated using narrow MW polystyrene standards. Since the samples were only partially soluble in the solvent due to cross-linking, the so-determined molecular weight distribution was for the soluble portion only. To determine the extent of cross-linking (solubility), a two hundred milligram sample cut from sheets were dissolved in 100 cc of 1,2,4-trichlorobenzene. Each sample was then heated to approximately 170° C. with N-phenyl-2-naphthyla-mine antioxidant added for 6 hours. The samples were then hot filtered at approximately 170° C. using separate preweighed high temperature filters for each sample.
- After filtration, the filters were cooled to room temperature and washed individually with dichloromethane. They were then placed in a convection oven at 105° C. for 6 hours to dry and then reweighed. The weight fraction of the undissolved (cross-linked) portion was then determined based upon the initial weight of 200 mg. To determine the low molecular weight fraction present in each sample, the weight fraction of molecular weight below 105 in the soluble portion, determined by GPC, was multiplied by the percent solubility to give weight percent of low molecular weight fraction in each sample. Results are shown in Table 3:
TABLE 3 Weight Percent Of Weight Soluble Percent Percent Of Portion Solubility In Entire Sample Sample Below 105 Solvent Below 105 Method 28.0 98.2 27.5 B/without oven aging Method B/11 36.2 100.0 36.2 day oven aging Method B/23 48.1 100.0 48.1 day oven aging Method 22.7 80.9 18.4 D/without oven aging Method D/11 20.5 73.6 15.1 day oven aging Method D/23 24.2 74.7 18.1 day oven aging - From Table 3, it can be seen that the sample made by Method D contains more cross-linking (i.e., less soluble) than one made by Method B. Upon oven aging, the low molecular weight fraction (defined as below 105) in the sample made by Method B increases from 0.275 to 0.481 while that of the sample made by Method D remains virtually unchanged at about 0.18 after 23 days of oven aging. The increase in low molecular weight fraction was due to chain scission caused by oxidative reactions. The results indicate that the process of method D can produce an irradiated polymer with a superior oxidation resistance.
- UHMWPE samples of 0.5 inch cubes prepared by Methods B and Method D cited in the Sample Preparation were evaluated for deformation under load (creep resistance). Testing procedures according to ASTM D 621 (A) (24 hr/23° C./1000 psi/90 mm recovery) were used. Results are summarized in Table 4:
TABLE 4 Sample Deformation Under Load % Method B 0.80 Method D 0.60 - From Table 4, it is concluded that the sample prepared by Method D, the invention, possesses a superior creep resistance (0.6%) to one prepared by Method B(0.8%).
- Two 1-mm-thick UHMWPE samples were annealed in an oven filled with air and dry nitrogen (oxygen concentration is below 0.2%) respectively at 130° C. for 20 hours in order to remove residual stress on the samples. After the sheets were cooled to room temperature in the oven, they were removed from the oven and cut into dumbbell shaped tensile specimens (ASTM D 638, Type V) for evaluation. A standard tensile test according to ASTM D 638 was performed at a speed of 2 inches/min for each of six specimens annealed in air and in dry nitrogen respectively. Results are shown in Table 5:
TABLE 5 TYS, TBS, Toughness, Sample EAB, % psi psi lbs-in/in3 Air 414 3547 6257 10,210 annealed Nitrogen 485 3517 8917 18,960 annealed
Note:
EAB—elongation at break
TYS—tensile yield strength
TBS—Tensile breaking strength
- From the above table, it is seen that the sample annealed in nitrogen exhibits a higher elongation at break, a higher tensile breaking strength, and a higher toughness, compared to one annealed in air, while the tensile yield strength is similar between the two samples. The results indicate that the sample annealed in nitrogen is more ductile than the one annealed in air. The loss of ductility in the sample annealed in air is due to oxidative chain scission.
- To determine oxidation indices in these two samples, a thin film specimen of ca. 100 microns in thickness was cut from each of the 1-mm-thick annealed UHMWPE sheets and placed in an IR window for a standard FTIR (a Nicolet 710 FTIR 10 system was used) transmission run, using the procedures and calculations employed in the Sample Preparation. Oxidation indices obtained are shown in Table 6.
TABLE 6 Sample Oxidation Index Air Annealed 0.10 Nitrogen Annealed ca. 0.0 - From the above results, it is seen that the UHMWPE sample annealed in air after ram extrusion showed significant oxidation due to free radicals generated in the forming process. In contrast, the UHMWPE sample annealed in nitrogen showed no oxidation (below the FTIR detectable level). It is concluded that annealing in nitrogen can prevent the polymer from oxidation and produce a polymer with superior ductility.
- While several examples of the present invention have been described, it is obvious that many changes and modifications may be made thereunto, without departing from the spirit and scope of the invention.
- Although the invention herein has been described with reference to particular embodiments, it is to be understood that these embodiments are merely illustrative of the principles and applications of the present invention. It is therefore to be understood that numerous modifications may be made to the illustrative embodiments and that other arrangements may be devised without departing from the spirit and scope of the present invention as defined by the appended claims.
Claims (19)
1. An irradiated ultra-high molecular weight polyethylene having a weight average molecular weight greater than 400,000 and having a FTIR (Fourier Transform Infra-red Spectroscopy) oxidation index which does not increase with oven aging at 80° C. for up to 11 days.
2. The polyethylene as set forth in claim 1 wherein the FTIR oxidation index of the polyethylene does not increase with oven aging in air at 80° C. for up to 23 days.
3. The polyethylene as set forth in claim 1 wherein the weight percent of the polyethylene having a molecular weight below 100,000 is less than 18.4%.
4. An ultra-high molecular weight polyethylene having a weight average molecular weight greater than 400,000, a solubility of less than 80.9% in trichlorobenzene and an oxidation index which does not increase during oven aging in air at 80° C. for up to 11 days.
5. The polyethylene as set forth in claim 4 wherein the level of free radicals is 1.0×1017/gram or less.
6. The polyethylene as set forth in claim 4 wherein the FTIR (Fourier Transform Infra-red Spectroscopy) oxidation index does not increase with oven aging in air at 80° C. for up to 23 days.
7. The polyethylene as set forth in claim 4 wherein the weight percent of the polyethylene having a molecular weight below 100,000 is less than 18.4%.
8. The polyethylene as set forth in claim 4 wherein the weight percent of the polyethylene having a molecular weight below 100,000 is less than 18.4%
9. An irradiated ultra-high molecular weight polyethylene having a weight average molecular weight greater than 400,000 and a solubility of less than 80.9% in 1,2,4-trichlorobenzene.
10. The irradiated ultra-high molecular weight polyethylene as set forth in claim 9 wherein the level of free radicals in the polyethylene is 1.0×1017/gram or less.
11. The irradiated ultra-high molecular weight polyethylene as set forth in claim 9 wherein the polyethylene has a FTIR (Fourier Transform Infra-red Spectroscopy) oxidation index which does not increase with oven aging in air at 80° C. for up to 11 days.
12. The irradiated ultra-high molecular weight polyethylene as set forth in claim 9 wherein the polyethylene has an FTIR (Fourier Transform Infra-red Spectroscopy) oxidation index which does not increase with oven aging in air at 80° C. for up to 23 days.
13. An irradiated ultra-high molecular weight polyethylene having a weight average molecular weight greater than 400,000 wherein the level of free radicals is 1.0×1017/gram or less and an oxidation index which does not increase during oven aging in air at 80° C. for 11 days.
14. An ultra-high molecular weight polyethylene having a weight average molecular weight greater than 400,000 irradiated and annealed at temperature greater than 25° C. for a sufficient time to have a solubility of less than 80.9% in trichlorobenzene and a non-increasing FTIR (Fourier Transform Infra-red Spectroscopy) oxidation index during oven aging in air at 80° C. for up to 11 days.
15. The polyethylene as set forth in claim 14 wherein the FTIR (Fourier Transform Infra-red Spectroscopy) oxidation index does not increase with oven aging in air at 80° C. for up to 23 days.
16. An ultra-high molecular weight polyethylene having a weight average molecular weight greater than 400,000 irradiated and annealed at a temperature greater than 25° C. for a sufficient time to have a level of free radicals of 1.0×1017/gram or less and an oxidation index which does not increase during oven aging in air at 80° C. for 11 days.
17. An ultra-high molecular weight polyethylene having a weight average molecular weight greater than 400,000 irradiated and annealed at a temperature greater than 25° C. for a sufficient time to have a non-increasing FTIR (Fourier Transform Infra-red Spectroscopy) oxidation index of 0.01 during oven aging in air at 80° C. for 11 days.
18. An ultra-high molecular weight polyethylene having a weight average molecular weight greater than 400,000 irradiated and annealed at a temperature greater than 25° C. for a sufficient time to have a non-increasing FTIR (Fourier Transform Infra-red Spectroscopy) oxidation index of 0.01 or less during oven aging in air at 80° C. for 11 days and a solubility of less than 80.9% in trichlorobenzene.
19. The polyethylene as set forth in claim 14 wherein the weight percent of the polyethylene having a molecular weight below 100,000 is less than 18.4%.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/935,510 US20050059750A1 (en) | 1993-06-01 | 2004-09-07 | Non-oxidizing polymeric medical implant |
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/070,074 US5414049A (en) | 1993-06-01 | 1993-06-01 | Non-oxidizing polymeric medical implant |
US08/320,705 US5449745A (en) | 1993-06-01 | 1994-10-07 | Non-oxidizing polymeric medical implant |
US08/439,028 US5650485A (en) | 1993-06-01 | 1995-05-11 | Non-oxidizing polymeric medical implant |
US08/733,067 US5728748A (en) | 1993-06-01 | 1996-10-16 | Non oxidizing polymeric medical implant |
US09/012,345 US6174934B1 (en) | 1993-06-01 | 1998-01-23 | Non-oxidizing polymeric medical implant |
US09/604,868 US6372814B1 (en) | 1993-06-01 | 2000-06-28 | Non-oxidizing polymeric medical implant |
US10/041,118 US6664308B2 (en) | 1993-06-01 | 2002-01-08 | Non-oxidizing polymeric medical implant |
US10/461,636 US6818020B2 (en) | 1993-06-01 | 2003-06-13 | Non-oxidizing polymeric medical implant |
US10/935,510 US20050059750A1 (en) | 1993-06-01 | 2004-09-07 | Non-oxidizing polymeric medical implant |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/461,636 Division US6818020B2 (en) | 1993-06-01 | 2003-06-13 | Non-oxidizing polymeric medical implant |
Publications (1)
Publication Number | Publication Date |
---|---|
US20050059750A1 true US20050059750A1 (en) | 2005-03-17 |
Family
ID=22092961
Family Applications (10)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/070,074 Expired - Lifetime US5414049A (en) | 1993-06-01 | 1993-06-01 | Non-oxidizing polymeric medical implant |
US08/320,705 Expired - Fee Related US5449745A (en) | 1993-06-01 | 1994-10-07 | Non-oxidizing polymeric medical implant |
US08/404,663 Expired - Lifetime US5543471A (en) | 1993-06-01 | 1995-03-15 | Non-oxidizing polymeric medical implant |
US08/439,028 Expired - Lifetime US5650485A (en) | 1993-06-01 | 1995-05-11 | Non-oxidizing polymeric medical implant |
US08/733,067 Expired - Lifetime US5728748A (en) | 1993-06-01 | 1996-10-16 | Non oxidizing polymeric medical implant |
US09/012,345 Expired - Fee Related US6174934B1 (en) | 1993-06-01 | 1998-01-23 | Non-oxidizing polymeric medical implant |
US09/604,868 Expired - Fee Related US6372814B1 (en) | 1993-06-01 | 2000-06-28 | Non-oxidizing polymeric medical implant |
US10/041,118 Expired - Fee Related US6664308B2 (en) | 1993-06-01 | 2002-01-08 | Non-oxidizing polymeric medical implant |
US10/461,636 Expired - Fee Related US6818020B2 (en) | 1993-06-01 | 2003-06-13 | Non-oxidizing polymeric medical implant |
US10/935,510 Abandoned US20050059750A1 (en) | 1993-06-01 | 2004-09-07 | Non-oxidizing polymeric medical implant |
Family Applications Before (9)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/070,074 Expired - Lifetime US5414049A (en) | 1993-06-01 | 1993-06-01 | Non-oxidizing polymeric medical implant |
US08/320,705 Expired - Fee Related US5449745A (en) | 1993-06-01 | 1994-10-07 | Non-oxidizing polymeric medical implant |
US08/404,663 Expired - Lifetime US5543471A (en) | 1993-06-01 | 1995-03-15 | Non-oxidizing polymeric medical implant |
US08/439,028 Expired - Lifetime US5650485A (en) | 1993-06-01 | 1995-05-11 | Non-oxidizing polymeric medical implant |
US08/733,067 Expired - Lifetime US5728748A (en) | 1993-06-01 | 1996-10-16 | Non oxidizing polymeric medical implant |
US09/012,345 Expired - Fee Related US6174934B1 (en) | 1993-06-01 | 1998-01-23 | Non-oxidizing polymeric medical implant |
US09/604,868 Expired - Fee Related US6372814B1 (en) | 1993-06-01 | 2000-06-28 | Non-oxidizing polymeric medical implant |
US10/041,118 Expired - Fee Related US6664308B2 (en) | 1993-06-01 | 2002-01-08 | Non-oxidizing polymeric medical implant |
US10/461,636 Expired - Fee Related US6818020B2 (en) | 1993-06-01 | 2003-06-13 | Non-oxidizing polymeric medical implant |
Country Status (9)
Country | Link |
---|---|
US (10) | US5414049A (en) |
EP (4) | EP0847765B1 (en) |
JP (1) | JP2836965B2 (en) |
AT (3) | ATE171078T1 (en) |
AU (1) | AU684500B2 (en) |
CA (1) | CA2162927C (en) |
DE (4) | DE69425838T2 (en) |
ES (1) | ES2122260T3 (en) |
WO (1) | WO1994027651A1 (en) |
Cited By (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060079596A1 (en) * | 2004-10-07 | 2006-04-13 | Schroeder David W | Crosslinked polymeric material with enhanced strength and process for manufacturing |
US20060079595A1 (en) * | 2004-10-07 | 2006-04-13 | Schroeder David W | Solid state deformation processing of crosslinked high molecular weight polymeric materials |
US20060280645A1 (en) * | 2005-06-02 | 2006-12-14 | Scott Sellers | Method for terminal sterilization of transdermal delivery devices |
US20060280644A1 (en) * | 2005-06-02 | 2006-12-14 | Scott Sellers | Method for terminal sterilization of transdermal delivery devices |
US20070059334A1 (en) * | 2005-08-18 | 2007-03-15 | Zimmer Technology, Inc. | Ultra high molecular weight polyethylene articles and methods of forming ultra high molecular weight polyethylene articles |
US20090030524A1 (en) * | 2007-07-27 | 2009-01-29 | Biomet Manufacturing Corp. | Antioxidant doping of crosslinked polymers to form non-eluting bearing components |
WO2009060043A2 (en) * | 2007-11-06 | 2009-05-14 | Dsm Ip Assets Bv | Process for producing high molecular weight polyethylene |
US20090212343A1 (en) * | 2005-06-15 | 2009-08-27 | Actel Corporation | Non-volatile two-transistor programmable logic cell and array layout |
US20100029858A1 (en) * | 2007-04-10 | 2010-02-04 | Zimmer, Inc. | Antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications |
US20100137481A1 (en) * | 2008-11-20 | 2010-06-03 | Zimmer Gmbh | Polyethylene materials |
US7858671B2 (en) | 1996-02-13 | 2010-12-28 | The General Hospital Corporation | Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices |
US20110028600A1 (en) * | 2007-04-10 | 2011-02-03 | Zimmer, Inc. | Antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications |
US20110178605A1 (en) * | 2010-01-21 | 2011-07-21 | Depuy Products, Inc. | Knee prosthesis system |
US8128703B2 (en) | 2007-09-28 | 2012-03-06 | Depuy Products, Inc. | Fixed-bearing knee prosthesis having interchangeable components |
US8187335B2 (en) | 2008-06-30 | 2012-05-29 | Depuy Products, Inc. | Posterior stabilized orthopaedic knee prosthesis having controlled condylar curvature |
US8192498B2 (en) | 2008-06-30 | 2012-06-05 | Depuy Products, Inc. | Posterior cructiate-retaining orthopaedic knee prosthesis having controlled condylar curvature |
US8206451B2 (en) | 2008-06-30 | 2012-06-26 | Depuy Products, Inc. | Posterior stabilized orthopaedic prosthesis |
US8236061B2 (en) | 2008-06-30 | 2012-08-07 | Depuy Products, Inc. | Orthopaedic knee prosthesis having controlled condylar curvature |
US8262976B2 (en) | 2004-10-07 | 2012-09-11 | Biomet Manufacturing Corp. | Solid state deformation processing of crosslinked high molecular weight polymeric materials |
US8399535B2 (en) | 2010-06-10 | 2013-03-19 | Zimmer, Inc. | Polymer [[s]] compositions including an antioxidant |
US8563623B2 (en) | 1996-02-13 | 2013-10-22 | The General Hospital Corporation | Radiation melt treated ultra high molecular weight polyethylene prosthetic devices |
USRE44762E1 (en) | 1994-09-21 | 2014-02-11 | Bmg Incorporated | Ultra high molecular weight polyethylene molded article for artificial joints and method of preparing the same |
US8652212B2 (en) | 2008-01-30 | 2014-02-18 | Zimmer, Inc. | Orthopedic component of low stiffness |
US8828086B2 (en) | 2008-06-30 | 2014-09-09 | Depuy (Ireland) | Orthopaedic femoral component having controlled condylar curvature |
US9119723B2 (en) | 2008-06-30 | 2015-09-01 | Depuy (Ireland) | Posterior stabilized orthopaedic prosthesis assembly |
US9168145B2 (en) | 2008-06-30 | 2015-10-27 | Depuy (Ireland) | Posterior stabilized orthopaedic knee prosthesis having controlled condylar curvature |
US9204967B2 (en) | 2007-09-28 | 2015-12-08 | Depuy (Ireland) | Fixed-bearing knee prosthesis having interchangeable components |
US9398956B2 (en) | 2007-09-25 | 2016-07-26 | Depuy (Ireland) | Fixed-bearing knee prosthesis having interchangeable components |
US9492280B2 (en) | 2000-11-28 | 2016-11-15 | Medidea, Llc | Multiple-cam, posterior-stabilized knee prosthesis |
US9586370B2 (en) | 2013-08-15 | 2017-03-07 | Biomet Manufacturing, Llc | Method for making ultra high molecular weight polyethylene |
US9708467B2 (en) | 2013-10-01 | 2017-07-18 | Zimmer, Inc. | Polymer compositions comprising one or more protected antioxidants |
US10184031B2 (en) | 2014-03-12 | 2019-01-22 | Zimmer, Inc. | Melt-stabilized ultra high molecular weight polyethylene and method of making the same |
US10265891B2 (en) | 2014-12-03 | 2019-04-23 | Zimmer, Inc. | Antioxidant-infused ultra high molecular weight polyethylene |
Families Citing this family (182)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5505984A (en) * | 1993-01-21 | 1996-04-09 | England; Garry L. | Method for forming biocompatible components using an isostatic press |
US5830396A (en) * | 1993-01-21 | 1998-11-03 | Biomet, Inc. | Method for processing thermoplastics, thermosets and elastomers |
US5414049A (en) * | 1993-06-01 | 1995-05-09 | Howmedica Inc. | Non-oxidizing polymeric medical implant |
US6800095B1 (en) | 1994-08-12 | 2004-10-05 | Diamicron, Inc. | Diamond-surfaced femoral head for use in a prosthetic joint |
US6514289B1 (en) | 2000-01-30 | 2003-02-04 | Diamicron, Inc. | Diamond articulation surface for use in a prosthetic joint |
US6494918B1 (en) | 2000-01-30 | 2002-12-17 | Diamicron, Inc. | Component for a prosthetic joint having a diamond load bearing and articulation surface |
US7494507B2 (en) * | 2000-01-30 | 2009-02-24 | Diamicron, Inc. | Articulating diamond-surfaced spinal implants |
US6596225B1 (en) | 2000-01-31 | 2003-07-22 | Diamicron, Inc. | Methods for manufacturing a diamond prosthetic joint component |
US6676704B1 (en) | 1994-08-12 | 2004-01-13 | Diamicron, Inc. | Prosthetic joint component having at least one sintered polycrystalline diamond compact articulation surface and substrate surface topographical features in said polycrystalline diamond compact |
US7678325B2 (en) * | 1999-12-08 | 2010-03-16 | Diamicron, Inc. | Use of a metal and Sn as a solvent material for the bulk crystallization and sintering of diamond to produce biocompatbile biomedical devices |
US6425922B1 (en) | 2000-01-30 | 2002-07-30 | Diamicron, Inc. | Prosthetic hip joint having at least one sintered polycrystalline diamond compact articulation surface |
US6290726B1 (en) | 2000-01-30 | 2001-09-18 | Diamicron, Inc. | Prosthetic hip joint having sintered polycrystalline diamond compact articulation surfaces |
JP3380642B2 (en) * | 1995-01-18 | 2003-02-24 | 本田技研工業株式会社 | Vehicle driving force calculation device |
CA2166450C (en) * | 1995-01-20 | 2008-03-25 | Ronald Salovey | Chemically crosslinked ultrahigh molecular weight polyethylene for artificial human joints |
US5577368A (en) * | 1995-04-03 | 1996-11-26 | Johnson & Johnson Professional, Inc. | Method for improving wear resistance of polymeric bioimplantable components |
US5674290A (en) * | 1995-04-05 | 1997-10-07 | Li; Shu-Tung | Water-stabilized biopolymeric implants |
ATE300964T1 (en) * | 1996-02-13 | 2005-08-15 | Massachusetts Inst Technology | RADIATED AND MELT-TREATED ULTRA HIGH MOLECULAR POLYETHYLENE PROSTHESES |
US5879400A (en) * | 1996-02-13 | 1999-03-09 | Massachusetts Institute Of Technology | Melt-irradiated ultra high molecular weight polyethylene prosthetic devices |
JP5073626B2 (en) * | 1996-02-13 | 2012-11-14 | マサチューセッツ インスティテュート オブ テクノロジー | Radiation and melt processed ultra high molecular weight polyethylene prosthetic device |
US20020156536A1 (en) * | 1996-02-13 | 2002-10-24 | Harris William H. | Polyethylene hip joint prosthesis with extended range of motion |
US5598937A (en) * | 1996-02-14 | 1997-02-04 | Keystone Industries, Inc. | Slackless drawbar assembly |
US5753182A (en) * | 1996-02-14 | 1998-05-19 | Biomet, Inc. | Method for reducing the number of free radicals present in ultrahigh molecular weight polyethylene orthopedic components |
US6228900B1 (en) | 1996-07-09 | 2001-05-08 | The Orthopaedic Hospital And University Of Southern California | Crosslinking of polyethylene for low wear using radiation and thermal treatments |
JP2000514481A (en) * | 1996-07-09 | 2000-10-31 | ザ オーソピーディック ホスピタル | Crosslinking of low wear polyethylene using radiation and heat treatment |
US6017975A (en) * | 1996-10-02 | 2000-01-25 | Saum; Kenneth Ashley | Process for medical implant of cross-linked ultrahigh molecular weight polyethylene having improved balance of wear properties and oxidation resistance |
WO1998016258A1 (en) * | 1996-10-15 | 1998-04-23 | The Orthopaedic Hospital | Wear resistant surface-gradient cross-linked polyethylene |
IT1298376B1 (en) * | 1997-12-16 | 2000-01-05 | Samo Spa | CROSS-LINKING AND STERILIZATION TREATMENT FOR THE PRODUCTION OF POLYETHYLENE PRODUCTS WITH HIGH TRIBOLOGICAL CHARACTERISTICS, |
US6692679B1 (en) * | 1998-06-10 | 2004-02-17 | Depuy Orthopaedics, Inc. | Cross-linked molded plastic bearings |
DE69922435T2 (en) * | 1998-06-10 | 2005-12-08 | Depuy Products, Inc., Warsaw | Method for producing crosslinked, molded plastic bearings |
EP1413414B1 (en) * | 1998-06-10 | 2006-12-13 | Depuy Products, Inc. | Method for forming cross-linked molded plastic bearings |
US5997969A (en) * | 1998-08-27 | 1999-12-07 | Gardon; John L. | Non-allergenic medical and health care devices made from crosslinked synthetic elastomers |
EP0995450B1 (en) * | 1998-10-21 | 2002-06-26 | Sulzer Orthopädie AG | UHMW-polyethylene for implants |
EP0995449A1 (en) | 1998-10-21 | 2000-04-26 | Sulzer Orthopädie AG | UHMW-polyethylene for implants |
JP4602556B2 (en) | 1998-11-20 | 2010-12-22 | コロプラスト アクティーゼルスカブ | Method for sterilizing medical devices having a hydrophilic coating |
US6986868B2 (en) * | 1998-11-20 | 2006-01-17 | Coloplast A/S | Method for sterilizing a medical device having a hydrophilic coating |
WO2000044093A1 (en) * | 1999-01-22 | 2000-07-27 | Multigig Limited | Electronic circuitry |
US6355215B1 (en) | 1999-03-10 | 2002-03-12 | Implex Corp. | Wear-resistant olefinic medical implant and thermal treatment container therefor |
US6203844B1 (en) * | 1999-04-01 | 2001-03-20 | Joon B. Park | Precoated polymeric prosthesis and process for making same |
WO2000062717A1 (en) | 1999-04-21 | 2000-10-26 | Howmedica Osteonics Corp. | Selectively cross-linked polyethylene orthopedic devices |
US6239197B1 (en) * | 1999-04-23 | 2001-05-29 | Great Lakes Chemical Corporation | Vacuum de-aerated powdered polymer additives |
US6627141B2 (en) | 1999-06-08 | 2003-09-30 | Depuy Orthopaedics, Inc. | Method for molding a cross-linked preform |
US6245276B1 (en) | 1999-06-08 | 2001-06-12 | Depuy Orthopaedics, Inc. | Method for molding a cross-linked preform |
US6432349B1 (en) | 1999-06-29 | 2002-08-13 | Zimmer, Inc. | Process of making an articulating bearing surface |
AU4890400A (en) * | 1999-07-29 | 2001-02-01 | Depuy Orthopaedics, Inc. | Two step gamma irradiation of polymeric bioimplant |
US6184265B1 (en) * | 1999-07-29 | 2001-02-06 | Depuy Orthopaedics, Inc. | Low temperature pressure stabilization of implant component |
EP1072277A1 (en) * | 1999-07-29 | 2001-01-31 | Depuy Orthopaedics, Inc. | Gamma irradiated heat treated implant for mechanical strength |
US6143232A (en) * | 1999-07-29 | 2000-11-07 | Bristol-Meyers Squibb Company | Method of manufacturing an articulating bearing surface for an orthopaedic implant |
US6794423B1 (en) * | 1999-07-30 | 2004-09-21 | Stephen Li | Fracture-resistant, cross-linked ultra high molecular weight polyethylene shaped material and articles made therefrom |
US6365089B1 (en) | 1999-09-24 | 2002-04-02 | Zimmer, Inc. | Method for crosslinking UHMWPE in an orthopaedic implant |
US7556763B2 (en) * | 1999-12-08 | 2009-07-07 | Diamicron, Inc. | Method of making components for prosthetic joints |
US7569176B2 (en) * | 1999-12-08 | 2009-08-04 | Diamicron, Inc. | Method for making a sintered superhard prosthetic joint component |
US6610095B1 (en) | 2000-01-30 | 2003-08-26 | Diamicron, Inc. | Prosthetic joint having substrate surface topographical featurers and at least one diamond articulation surface |
US20100025898A1 (en) * | 2000-01-30 | 2010-02-04 | Pope Bill J | USE OF Ti AND Nb CEMENTED TiC IN PROSTHETIC JOINTS |
US8603181B2 (en) * | 2000-01-30 | 2013-12-10 | Dimicron, Inc | Use of Ti and Nb cemented in TiC in prosthetic joints |
US6410877B1 (en) | 2000-01-30 | 2002-06-25 | Diamicron, Inc. | Methods for shaping and finishing prosthetic joint components including polycrystalline diamond compacts |
US6709463B1 (en) | 2000-01-30 | 2004-03-23 | Diamicron, Inc. | Prosthetic joint component having at least one solid polycrystalline diamond component |
US20040199260A1 (en) * | 2000-01-30 | 2004-10-07 | Pope Bill J. | Prosthetic joint component having at least one sintered polycrystalline diamond compact articulation surface and substrate surface topographical features in said polycrystalline diamond compact |
US20050203630A1 (en) * | 2000-01-30 | 2005-09-15 | Pope Bill J. | Prosthetic knee joint having at least one diamond articulation surface |
US6395799B1 (en) | 2000-02-21 | 2002-05-28 | Smith & Nephew, Inc. | Electromagnetic and mechanical wave energy treatments of UHMWPE |
US6414086B1 (en) | 2000-02-29 | 2002-07-02 | Howmedica Osteonics Corp. | Compositions, processes and methods of improving the wear resistance of prosthetic medical devices |
US6626945B2 (en) | 2000-03-14 | 2003-09-30 | Chondrosite, Llc | Cartilage repair plug |
US6632246B1 (en) | 2000-03-14 | 2003-10-14 | Chondrosite, Llc | Cartilage repair plug |
DE60137212D1 (en) * | 2000-04-27 | 2009-02-12 | Orthopaedic Hospital | OXIDATION-RESISTANT AND ABRASION-RESISTANT POLYETHYLENE FOR HUMAN JOINT KIT AND METHOD FOR THE PRODUCTION THEREOF |
JP4354181B2 (en) | 2000-07-31 | 2009-10-28 | ザ・ジェネラル・ホスピタル・コーポレイション | Improved acetabular component that reduces the risk of dislocation |
US6579532B1 (en) * | 2000-09-08 | 2003-06-17 | Ferro Corporation | Orthopedic mixtures prepared by supercritical fluid processing techniques |
AU9319201A (en) * | 2000-09-29 | 2002-04-08 | Depuy Orthopaedics Inc | Supercritical fluid treatment of irradiated polyethylene |
US6818172B2 (en) | 2000-09-29 | 2004-11-16 | Depuy Products, Inc. | Oriented, cross-linked UHMWPE molding for orthopaedic applications |
DE10105085C1 (en) * | 2001-02-05 | 2002-04-18 | Plus Endoprothetik Ag Rotkreuz | Production of implant part, e.g. bearing for hip prosthesis, by crosslinking ultra-high molecular weight polyethylene parison with ionizing radiation includes recombination of free radicals with microwaves and/or ultrasound |
JP3360073B2 (en) * | 2001-02-22 | 2002-12-24 | 花王株式会社 | Drink |
US6547828B2 (en) | 2001-02-23 | 2003-04-15 | Smith & Nephew, Inc. | Cross-linked ultra-high molecular weight polyethylene for medical implant use |
JP3757264B2 (en) * | 2001-03-27 | 2006-03-22 | 独立行政法人産業技術総合研究所 | Silsesquioxane-based polymer molded body and method for producing the same |
US6655845B1 (en) * | 2001-04-22 | 2003-12-02 | Diamicron, Inc. | Bearings, races and components thereof having diamond and other superhard surfaces |
US20030019106A1 (en) * | 2001-04-22 | 2003-01-30 | Diamicron, Inc. | Methods for making bearings, races and components thereof having diamond and other superhard surfaces |
US9155626B2 (en) | 2012-09-10 | 2015-10-13 | Acumed Llc | Radial head prosthesis with floating articular member |
US7695521B2 (en) | 2001-05-01 | 2010-04-13 | Amedica Corporation | Hip prosthesis with monoblock ceramic acetabular cup |
US7776085B2 (en) | 2001-05-01 | 2010-08-17 | Amedica Corporation | Knee prosthesis with ceramic tibial component |
DK2055267T3 (en) * | 2001-05-01 | 2013-07-01 | Amedica Corp | Beam permeable bone graft |
WO2002102275A2 (en) | 2001-06-14 | 2002-12-27 | Amedica Corporation | Metal-ceramic composite articulation |
US6652586B2 (en) * | 2001-07-18 | 2003-11-25 | Smith & Nephew, Inc. | Prosthetic devices employing oxidized zirconium and other abrasion resistant surfaces contacting surfaces of cross-linked polyethylene |
US7182784B2 (en) * | 2001-07-18 | 2007-02-27 | Smith & Nephew, Inc. | Prosthetic devices employing oxidized zirconium and other abrasion resistant surfaces contacting surfaces of cross-linked polyethylene |
GB0122117D0 (en) * | 2001-09-13 | 2001-10-31 | United Ind Operations Ltd | Method of crosslinking polyolefins |
DE10149884B4 (en) * | 2001-10-10 | 2005-02-17 | Hubert Rosing | Process for the production of semi-finished products from high or ultra-high molecular weight polymers, semifinished products thus produced and their use |
US7150853B2 (en) * | 2001-11-01 | 2006-12-19 | Advanced Cardiovascular Systems, Inc. | Method of sterilizing a medical device |
DE10160329A1 (en) * | 2001-12-07 | 2003-06-18 | Merck Patent Gmbh | Polymer-based material containing silica particles |
EP1467854A4 (en) * | 2001-12-12 | 2007-01-10 | Depuy Products Inc | Orthopaedic device and method for making same |
US6852772B2 (en) * | 2002-01-04 | 2005-02-08 | Massachusetts Gerneral Hospital | High modulus crosslinked polyethylene with reduced residual free radical concentration prepared below the melt |
EP1332733B1 (en) | 2002-01-28 | 2006-06-14 | Depuy Products, Inc. | Composite prosthetic bearing and method of manufacture |
US7819925B2 (en) * | 2002-01-28 | 2010-10-26 | Depuy Products, Inc. | Composite prosthetic bearing having a crosslinked articulating surface and method for making the same |
US7186364B2 (en) * | 2002-01-28 | 2007-03-06 | Depuy Products, Inc. | Composite prosthetic bearing constructed of polyethylene and an ethylene-acrylate copolymer and method for making the same |
ATE312704T1 (en) | 2002-01-29 | 2005-12-15 | Paul Smith | SINTERING OF ULTRA HIGH MOLECULAR POLYETHYLENE |
EP1369094B1 (en) | 2002-05-31 | 2014-11-26 | Zimmer GmbH | Implant and method of manufacturing a sterile packaged implant |
CA2429930C (en) * | 2002-06-06 | 2008-10-14 | Howmedica Osteonics Corp. | Sequentially cross-linked polyethylene |
US20040002770A1 (en) * | 2002-06-28 | 2004-01-01 | King Richard S. | Polymer-bioceramic composite for orthopaedic applications and method of manufacture thereof |
ATE376083T1 (en) * | 2002-12-10 | 2007-11-15 | Dsm Ip Assets Bv | METHOD FOR PRODUCING AND METHOD FOR CONVERSING POLYOLEFINE FIBERS |
US6994727B2 (en) | 2002-12-17 | 2006-02-07 | Amedica Corporation | Total disc implant |
EP2664299A1 (en) * | 2003-01-16 | 2013-11-20 | Massachusetts General Hospital | Methods For Making Oxidation Resistant Polymeric Material |
US7938861B2 (en) * | 2003-04-15 | 2011-05-10 | Depuy Products, Inc. | Implantable orthopaedic device and method for making the same |
EP1624906A1 (en) * | 2003-05-19 | 2006-02-15 | Tjaart Andries Du Plessis | Preparation of an osteoinductive agent |
US20060243624A1 (en) * | 2003-06-10 | 2006-11-02 | Meadwestvaco Corporation | Resin packaging |
US20040265165A1 (en) * | 2003-06-30 | 2004-12-30 | Depuy Products, Inc. | Free radical quench process for irradiated ultrahigh molecular weight polyethylene |
US7214764B2 (en) * | 2003-06-30 | 2007-05-08 | Depuy Products, Inc. | Free radical quench process for irradiated ultrahigh molecular weight polyethylene |
US20040262809A1 (en) * | 2003-06-30 | 2004-12-30 | Smith Todd S. | Crosslinked polymeric composite for orthopaedic implants |
US20050133277A1 (en) * | 2003-08-28 | 2005-06-23 | Diamicron, Inc. | Superhard mill cutters and related methods |
US20050065307A1 (en) * | 2003-09-19 | 2005-03-24 | Depuy Products, Inc. | Medical implant or medical implant part comprising porous UHMWPE and process for producing the same |
US7205051B2 (en) * | 2003-09-30 | 2007-04-17 | Depuy Products, Inc. | Medical implant or medical implant part |
US6996952B2 (en) * | 2003-09-30 | 2006-02-14 | Codman & Shurtleff, Inc. | Method for improving stability and effectivity of a drug-device combination product |
EP1732476B1 (en) * | 2004-03-11 | 2017-02-01 | Acumed LLC | Systems for bone replacement |
US7833452B2 (en) | 2004-05-11 | 2010-11-16 | The General Hospital Corporation | Method for making oxidation resistant polymeric material |
US7384430B2 (en) * | 2004-06-30 | 2008-06-10 | Depuy Products, Inc. | Low crystalline polymeric material for orthopaedic implants and an associated method |
US7547405B2 (en) | 2004-10-07 | 2009-06-16 | Biomet Manufacturing Corp. | Solid state deformation processing of crosslinked high molecular weight polymeric materials |
US20060142868A1 (en) * | 2004-12-21 | 2006-06-29 | Zimmer Technology, Inc. | Selective crosslinking of orthopaedic implants |
US7335697B2 (en) * | 2004-12-23 | 2008-02-26 | Depuy Products, Inc. | Polymer composition comprising cross-linked polyethylene and methods for making the same |
US7896921B2 (en) * | 2004-12-30 | 2011-03-01 | Depuy Products, Inc. | Orthopaedic bearing and method for making the same |
US7879275B2 (en) * | 2004-12-30 | 2011-02-01 | Depuy Products, Inc. | Orthopaedic bearing and method for making the same |
US7883653B2 (en) | 2004-12-30 | 2011-02-08 | Depuy Products, Inc. | Method of making an implantable orthopaedic bearing |
US7435372B2 (en) * | 2005-03-31 | 2008-10-14 | Zimmer, Inc. | Liquid bath annealing of polymers for orthopaedic implants |
US8449991B2 (en) * | 2005-04-07 | 2013-05-28 | Dimicron, Inc. | Use of SN and pore size control to improve biocompatibility in polycrystalline diamond compacts |
EP1872784A4 (en) * | 2005-04-20 | 2012-06-20 | Senju Pharma Co | Medicinal preparation for percutaneous absorption |
AU2006259555B2 (en) | 2005-06-14 | 2011-03-03 | Omni Life Science, Inc. | Crosslinked polyethylene article |
US8461225B2 (en) * | 2005-08-22 | 2013-06-11 | The General Hospital Corporation | Oxidation resistant homogenized polymeric material |
US8343230B2 (en) * | 2005-09-22 | 2013-01-01 | Depuy Products, Inc. | Orthopaedic bearing material |
US20070077268A1 (en) * | 2005-09-30 | 2007-04-05 | Depuy Products, Inc. | Hydrophobic carrier modified implants for beneficial agent delivery |
US8252058B2 (en) | 2006-02-16 | 2012-08-28 | Amedica Corporation | Spinal implant with elliptical articulatory interface |
US20070209957A1 (en) * | 2006-03-09 | 2007-09-13 | Sdgi Holdings, Inc. | Packaging system for medical devices |
US7812098B2 (en) * | 2006-03-31 | 2010-10-12 | Depuy Products, Inc. | Bearing material of medical implant having reduced wear rate and method for reducing wear rate |
US20070232716A1 (en) * | 2006-04-04 | 2007-10-04 | Fina Technology, Inc. | Cross-linking resins |
US20080036111A1 (en) * | 2006-08-09 | 2008-02-14 | Dehchuan Sun | Non-oxidizing thermally crosslinked polymeric material and medical implant |
DE602007009345D1 (en) * | 2006-08-25 | 2010-11-04 | Depuy Products Inc | Material for carrying a medical implant |
ES2615462T3 (en) * | 2006-09-01 | 2017-06-07 | Basf Se | Recovery of bisphenol ligands during the preparation of isopulegol |
JP2010508405A (en) * | 2006-10-30 | 2010-03-18 | スミス アンド ネフュー オーソペディックス アーゲー | Method involving polyethylene cross-linking or using cross-linked polyethylene |
US8562616B2 (en) | 2007-10-10 | 2013-10-22 | Biomet Manufacturing, Llc | Knee joint prosthesis system and method for implantation |
US8187280B2 (en) | 2007-10-10 | 2012-05-29 | Biomet Manufacturing Corp. | Knee joint prosthesis system and method for implantation |
US8328873B2 (en) | 2007-01-10 | 2012-12-11 | Biomet Manufacturing Corp. | Knee joint prosthesis system and method for implantation |
US8163028B2 (en) | 2007-01-10 | 2012-04-24 | Biomet Manufacturing Corp. | Knee joint prosthesis system and method for implantation |
US8157869B2 (en) | 2007-01-10 | 2012-04-17 | Biomet Manufacturing Corp. | Knee joint prosthesis system and method for implantation |
ATE555636T1 (en) | 2007-01-25 | 2012-05-15 | Gen Hospital Corp | METHOD FOR PRODUCING OXIDATION-RESISTANT CROSS-LINKED POLYMER MATERIAL |
WO2008101116A1 (en) * | 2007-02-14 | 2008-08-21 | Brigham And Women's Hospital, Inc. | Crosslinked polymers and methods of making the same |
AU2007349695A1 (en) * | 2007-03-20 | 2008-09-25 | Smith & Nephew Orthopaedics Ag | Oxidation resistant highly-crosslinked UHMWPE |
MX2009010351A (en) * | 2007-03-27 | 2009-10-19 | Dsm Ip Assets Bv | Process for removing residual spin solvent from a gel spun filament, the filament, multi-filament yarn and products comprising the filament. |
JP6223653B2 (en) * | 2007-09-04 | 2017-11-01 | スミス・アンド・ネフュー・オルソペディクス・アーゲー | Ultra high molecular weight polyethylene for joint surfaces |
US8715359B2 (en) | 2009-10-30 | 2014-05-06 | Depuy (Ireland) | Prosthesis for cemented fixation and method for making the prosthesis |
US20110035018A1 (en) * | 2007-09-25 | 2011-02-10 | Depuy Products, Inc. | Prosthesis with composite component |
US20110035017A1 (en) * | 2007-09-25 | 2011-02-10 | Depuy Products, Inc. | Prosthesis with cut-off pegs and surgical method |
EP2209726A4 (en) * | 2007-10-12 | 2012-08-15 | Peak Plastic & Metal Prod | Wafer container with staggered wall structure |
US8586667B2 (en) * | 2008-05-13 | 2013-11-19 | Smith & Nephew Orthopaedics Ag | Oxidation resistant highly-crosslinked UHMWPE |
US20090288366A1 (en) | 2008-05-23 | 2009-11-26 | Phillip Andrew Schorr | Vacuum packaged products and methods for making same |
US9095324B2 (en) * | 2008-06-20 | 2015-08-04 | Boston Scientific Scimed, Inc. | Package assembly |
US20100022677A1 (en) * | 2008-07-24 | 2010-01-28 | Zimmer, Inc. | Reduction of free radicals in crosslinked polyethylene by infrared heating |
US20100022678A1 (en) * | 2008-07-24 | 2010-01-28 | Zimmer, Inc. | Reduction of free radicals in crosslinked polyethylene by infrared heating |
US8133436B2 (en) * | 2008-08-05 | 2012-03-13 | Howmedica Osteonics Corp. | Polyethylene cross-linked with an anthocyanin |
US8765040B2 (en) * | 2008-08-11 | 2014-07-01 | Abbott Cardiovascular Systems Inc. | Medical device fabrication process including strain induced crystallization with enhanced crystallization |
DE102008053793A1 (en) | 2008-10-21 | 2010-04-22 | Aesculap Ag | Synthetic polymer material, useful for producing medical articles e.g. catheters and trocar, comprises amino acids and/or peptides having anti-oxidative effect |
US11213397B2 (en) | 2009-05-21 | 2022-01-04 | Depuy Ireland Unlimited Company | Prosthesis with surfaces having different textures and method of making the prosthesis |
US9101476B2 (en) | 2009-05-21 | 2015-08-11 | Depuy (Ireland) | Prosthesis with surfaces having different textures and method of making the prosthesis |
US8663359B2 (en) * | 2009-06-26 | 2014-03-04 | Dimicron, Inc. | Thick sintered polycrystalline diamond and sintered jewelry |
ES2408583T3 (en) | 2009-10-30 | 2013-06-21 | Depuy Products, Inc. | Prosthesis with surfaces with different textures |
EP2319462B1 (en) | 2009-10-30 | 2013-04-03 | DePuy Products, Inc. | Prosthesis with composite component |
DK2316382T3 (en) | 2009-10-30 | 2014-05-12 | Depuy Ireland | Prosthesis for uncemented fixation |
EP2319460A1 (en) | 2009-10-30 | 2011-05-11 | DePuy Products, Inc. | Prosthesis with cut-off pegs |
ES2406154T3 (en) | 2009-10-30 | 2013-06-05 | Depuy Products, Inc. | Prosthetics with modular extensions |
WO2011090942A1 (en) | 2010-01-22 | 2011-07-28 | Allegiance Corporation | Methods for packaging and sterilizing elastomeric articles, and packaged elastomeric articles produced thereby |
US8613880B2 (en) | 2010-04-21 | 2013-12-24 | Abbott Cardiovascular Systems Inc. | Post electron beam conditioning of polymeric medical devices |
US8715569B2 (en) * | 2010-08-20 | 2014-05-06 | Abbott Cardiovascular Systems Inc. | Post electron beam stabilization of polymeric medical devices |
US9132209B2 (en) | 2010-05-07 | 2015-09-15 | Howmedia Osteonics Corp. | Surface crosslinked polyethylene |
US8235209B2 (en) | 2010-08-11 | 2012-08-07 | Boston Scientific Scimed, Inc. | Medical device packaging and methods for preparing and packaging medical devices |
US8973748B2 (en) | 2011-01-19 | 2015-03-10 | Boston Scientific Scime, Inc. | Medical device packaging and methods for preparing and packaging medical devices |
US9096368B2 (en) | 2011-01-19 | 2015-08-04 | Boston Scientific Scimed, Inc. | Medical device packaging and methods for preparing and packaging medical devices |
US8966868B2 (en) * | 2011-05-09 | 2015-03-03 | Abbott Cardiovascular Systems Inc. | Methods of stabilizing molecular weight of polymer stents after sterilization |
US8556970B2 (en) | 2011-09-28 | 2013-10-15 | Depuy Mitek, Llc | Graft introducer |
US20140262858A1 (en) * | 2011-10-21 | 2014-09-18 | Ranbaxy Laboratories Limited | Packaging for alitretinoin |
DE102012010155B4 (en) * | 2012-05-24 | 2015-06-11 | Pan-Biotech Gmbh | Cell culture container for single use |
BR112015021586B1 (en) | 2013-03-14 | 2023-01-31 | Fresenius Kabi Deutschland Gmbh | INJECTABLE PHARMACEUTICAL MORPHINE FORMULATION AND KIT |
DK2968729T3 (en) | 2013-03-14 | 2018-12-03 | Fresenius Kabi Deutschland Gmbh | OXYGEN SENSITIVE PACKAGING SYSTEM |
US9237953B2 (en) | 2013-03-15 | 2016-01-19 | Depuy (Ireland) | Mechanical assembly of pegs to prosthesis |
US20160279055A1 (en) | 2013-07-22 | 2016-09-29 | Imprimis Pharmaceuticals, Inc. | Pharmaceutical ophthalmic compositions for intraocular administration and methods for fabricating thereof |
US9144499B2 (en) | 2013-12-17 | 2015-09-29 | Depuy (Ireland) | Low profile mobile/fixed prosthetic knee systems |
US20150266210A1 (en) | 2014-03-21 | 2015-09-24 | Howmedica Osteonics Corp. | Annealing method for cross-linked polyethylene |
US9763792B2 (en) | 2015-10-01 | 2017-09-19 | Acumed Llc | Radial head prosthesis with rotate-to-lock interface |
US10070959B2 (en) | 2016-09-28 | 2018-09-11 | DePuy Synthes Products, Inc. | Method of texturing prosthetic implants |
WO2021154204A1 (en) | 2020-01-27 | 2021-08-05 | Formosa Plastics Corporation, U.S.A. | Process for preparing catalysts and catalyst compositions |
US11952439B2 (en) | 2020-06-25 | 2024-04-09 | b-ONE Medical (Suzhou) Co., Ltd. | Surface gradient cross-linking method of ultra-high molecular weight polyethylene and the application thereof |
WO2023239560A1 (en) | 2022-06-09 | 2023-12-14 | Formosa Plastics Corporaton, U.S.A. | Clay composite support-activators and catalyst compositions |
Citations (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2904480A (en) * | 1955-06-06 | 1959-09-15 | Grace W R & Co | Polyethylene |
US3022543A (en) * | 1958-02-07 | 1962-02-27 | Grace W R & Co | Method of producing film having improved shrink energy |
US3057791A (en) * | 1959-07-06 | 1962-10-09 | Phillips Petroleum Co | Radiation curing of polymers |
US3090770A (en) * | 1960-04-26 | 1963-05-21 | Grace W R & Co | Blended polyethylene compositions of improved clarity and method of making same |
US3162623A (en) * | 1961-12-26 | 1964-12-22 | Du Pont | Crosslinking of polymers with nitrogen fluorides |
US3297641A (en) * | 1964-01-17 | 1967-01-10 | Grace W R & Co | Process for cross-linking polyethylene |
US3330748A (en) * | 1955-01-11 | 1967-07-11 | Gen Electric | Method and apparatus for irradiating organic polymers with electrons |
US3352818A (en) * | 1964-01-31 | 1967-11-14 | Glanzstoff Ag | Stability of polyolefines |
US3362897A (en) * | 1962-11-21 | 1968-01-09 | Gen Electric | Stable irradiated polyethylene |
US3563869A (en) * | 1957-11-05 | 1971-02-16 | Grace W R & Co | Irradiated polyethylene |
US3616365A (en) * | 1966-05-27 | 1971-10-26 | Basf Ag | Process of making particulate expanded olefin polymers having high thermal stability |
US3758273A (en) * | 1970-04-03 | 1973-09-11 | Gillette Co | Processes for sterilizing polypropylene objects |
US3832827A (en) * | 1967-12-18 | 1974-09-03 | J Lemelson | Container forming and filling apparatus |
US3886056A (en) * | 1971-11-01 | 1975-05-27 | Ryozo Kitamaru | Process for producing a high melting temperature polyethylene employing irradiation and orienting |
US4226905A (en) * | 1978-04-18 | 1980-10-07 | Du Pont Canada Inc. | Manufacture of film from partially crosslinked polyethylene |
US4587163A (en) * | 1984-03-06 | 1986-05-06 | Zachariades Anagnostis E | Preparation of ultra high molecular weight polyethylene morphologies of totally fused particles with superior mechanical performance |
US4655769A (en) * | 1984-10-24 | 1987-04-07 | Zachariades Anagnostis E | Ultra-high-molecular-weight polyethylene products including vascular prosthesis devices and methods relating thereto and employing pseudo-gel states |
US4701288A (en) * | 1985-06-05 | 1987-10-20 | Bausch & Lomb Incorporated | Method of making articles of dissimilar polymer compositions |
US4813210A (en) * | 1985-09-27 | 1989-03-21 | Nissho Corporation | Radiation-sterilized, packaged medical device |
US4820466A (en) * | 1985-01-31 | 1989-04-11 | Zachariades Anagnostis E | Process for obtaining ultra-high modulus products |
US4832965A (en) * | 1985-05-17 | 1989-05-23 | Helin Stig Aake | Method of making a bottle and packaging a water ration therein |
US4950151A (en) * | 1985-01-31 | 1990-08-21 | Zachariades Anagnostic E | Rolling die for producing high modulus products |
US5030402A (en) * | 1989-03-17 | 1991-07-09 | Zachariades Anagnostis E | Process for producing a new class of ultra-high-molecular-weight polyethylene orthopaedic prostheses with enhanced mechanical properties |
US5037928A (en) * | 1989-10-24 | 1991-08-06 | E. I. Du Pont De Nemours And Company | Process of manufacturing ultrahigh molecular weight linear polyethylene shaped articles |
US5047446A (en) * | 1988-07-22 | 1991-09-10 | Himont Incorporated | Thermal treatment of irradiated propylene polymer material |
US5096654A (en) * | 1987-07-24 | 1992-03-17 | The National Research And Development Corporation | Solid phase deformation process |
US5153039A (en) * | 1990-03-20 | 1992-10-06 | Paxon Polymer Company, L.P. | High density polyethylene article with oxygen barrier properties |
US5160677A (en) * | 1989-12-15 | 1992-11-03 | United States Surgical Corporation | Pressurized powder support for treating processes |
US5160464A (en) * | 1983-12-09 | 1992-11-03 | National Research Development Corporation | Polymer irradiation |
US5200439A (en) * | 1990-04-13 | 1993-04-06 | Mitsui Toatsu Chemicals, Inc. | Method for increasing intrinsic viscosity of syndiotactic polypropylene |
US5352732A (en) * | 1990-08-07 | 1994-10-04 | E. I. Du Pont De Nemours And Company | Homogeneous, high modulus ultrahigh molecular weight polyethylene composites and processes for the preparation thereof |
US5428079A (en) * | 1990-08-01 | 1995-06-27 | Dsm N.V. | Solution of ultra-high molecular weight polyethylene |
US5466530A (en) * | 1993-01-21 | 1995-11-14 | England; Garry L. | Biocompatible components fabricated from a substantially consolidated stock of material |
US5508319A (en) * | 1991-06-21 | 1996-04-16 | Montell North America Inc. | High melt strength, ethylene polymer, process for making it, and use thereof |
US5543471A (en) * | 1993-06-01 | 1996-08-06 | Howmedica Inc. | Non-oxidizing polymeric medical implant |
US5577368A (en) * | 1995-04-03 | 1996-11-26 | Johnson & Johnson Professional, Inc. | Method for improving wear resistance of polymeric bioimplantable components |
US5753182A (en) * | 1996-02-14 | 1998-05-19 | Biomet, Inc. | Method for reducing the number of free radicals present in ultrahigh molecular weight polyethylene orthopedic components |
US5874123A (en) * | 1997-01-24 | 1999-02-23 | Park; Joon B. | Precoated polymeric prosthesis and process for making same |
US5879400A (en) * | 1996-02-13 | 1999-03-09 | Massachusetts Institute Of Technology | Melt-irradiated ultra high molecular weight polyethylene prosthetic devices |
US6017975A (en) * | 1996-10-02 | 2000-01-25 | Saum; Kenneth Ashley | Process for medical implant of cross-linked ultrahigh molecular weight polyethylene having improved balance of wear properties and oxidation resistance |
US6143232A (en) * | 1999-07-29 | 2000-11-07 | Bristol-Meyers Squibb Company | Method of manufacturing an articulating bearing surface for an orthopaedic implant |
US6168626B1 (en) * | 1994-09-21 | 2001-01-02 | Bmg Incorporated | Ultra high molecular weight polyethylene molded article for artificial joints and method of preparing the same |
US6184265B1 (en) * | 1999-07-29 | 2001-02-06 | Depuy Orthopaedics, Inc. | Low temperature pressure stabilization of implant component |
US6228900B1 (en) * | 1996-07-09 | 2001-05-08 | The Orthopaedic Hospital And University Of Southern California | Crosslinking of polyethylene for low wear using radiation and thermal treatments |
US6272814B1 (en) * | 1999-11-22 | 2001-08-14 | Wakai & Co., Ltd. | Method of packaging nut assemblies |
US6281264B1 (en) * | 1995-01-20 | 2001-08-28 | The Orthopaedic Hospital | Chemically crosslinked ultrahigh molecular weight polyethylene for artificial human joints |
US20020013781A1 (en) * | 2000-01-13 | 2002-01-31 | Erik Petersen | System and method of searchin and gathering information on-line and off-line |
US6395799B1 (en) * | 2000-02-21 | 2002-05-28 | Smith & Nephew, Inc. | Electromagnetic and mechanical wave energy treatments of UHMWPE |
US6432349B1 (en) * | 1999-06-29 | 2002-08-13 | Zimmer, Inc. | Process of making an articulating bearing surface |
US6494917B1 (en) * | 1996-10-15 | 2002-12-17 | Orthopaedic Hospital | Wear resistant surface-gradient crosslinked polyethylene |
US6503439B1 (en) * | 2000-06-15 | 2003-01-07 | Albert H. Burstein | Process for forming shaped articles of ultra high molecular weight polyethylene suitable for use as a prosthetic device or a component thereof |
US6547828B2 (en) * | 2001-02-23 | 2003-04-15 | Smith & Nephew, Inc. | Cross-linked ultra-high molecular weight polyethylene for medical implant use |
US6641617B1 (en) * | 1996-02-13 | 2003-11-04 | The General Hospital Corp. | Radiation and melt treated ultra high molecular weight polyethylene prosthetic device and method |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1324919A (en) * | 1970-11-13 | 1973-07-25 | Atomic Energy Commission | Preparation of filled polyethylenes |
US4241463A (en) | 1978-10-16 | 1980-12-30 | Precision Cast Specialties, Inc. | Prosthetic implant device |
GB2060469B (en) * | 1979-06-06 | 1983-09-28 | Nat Res Dev | Drawing thermoplastics material |
US5017627A (en) | 1980-10-09 | 1991-05-21 | National Research Development Corporation | Composite material for use in orthopaedics |
US4586995A (en) * | 1982-09-17 | 1986-05-06 | Phillips Petroleum Company | Polymer and irradiation treatment method |
JPS5971830A (en) | 1982-10-18 | 1984-04-23 | Nippon Sheet Glass Co Ltd | Manufacture of lens of refractive index distribution type |
CA1252265A (en) * | 1984-03-30 | 1989-04-11 | Ian M. Ward | Tubular materials |
EP0161802B1 (en) * | 1984-04-13 | 1990-06-27 | National Research Development Corporation | Solid phase deformation process |
ZA86528B (en) | 1985-01-31 | 1986-09-24 | Himont Inc | Polypropylene with free-end long chain branching,process for making it,and use thereof |
US4965846A (en) * | 1986-08-11 | 1990-10-23 | Baxter International Inc. | Pivot pin bearing/seal with loose eyelet especially suited for disposable continuous flow blood filtration system cartridges |
GB8827967D0 (en) * | 1988-11-30 | 1989-01-05 | Ward I M | Die-free drawing |
ES2087147T3 (en) * | 1988-12-02 | 1996-07-16 | Du Pont | LINEAR POLYETHYLENE OF ULTRAELEVADO MOLECULAR WEIGHT, ARTICLES AND MANUFACTURING PROCEDURES. |
WO1990006140A1 (en) * | 1988-12-02 | 1990-06-14 | E.I. Du Pont De Nemours And Company | Process of manufacturing ultrahigh molecular weight linear polyethylene shaped articles |
CA2031406C (en) | 1989-12-21 | 2002-05-28 | Paolo Galli | Graft copolymers of polyolefins and a method of producing same |
US5292584A (en) | 1991-04-11 | 1994-03-08 | E. I. Du Pont De Nemours And Company | Ultrahigh molecular weight polyethylene and lightly-filled composites thereof |
AU7634094A (en) | 1993-08-20 | 1995-03-21 | Smith & Nephew Richards Inc. | Self-reinforced ultra-high molecular weight polyethylene composites |
US5609643A (en) | 1995-03-13 | 1997-03-11 | Johnson & Johnson Professional, Inc. | Knee joint prosthesis |
-
1993
- 1993-06-01 US US08/070,074 patent/US5414049A/en not_active Expired - Lifetime
-
1994
- 1994-04-26 DE DE69425838T patent/DE69425838T2/en not_active Expired - Lifetime
- 1994-04-26 CA CA002162927A patent/CA2162927C/en not_active Expired - Fee Related
- 1994-04-26 EP EP98103006A patent/EP0847765B1/en not_active Expired - Lifetime
- 1994-04-26 ES ES94912052T patent/ES2122260T3/en not_active Expired - Lifetime
- 1994-04-26 AT AT94912052T patent/ATE171078T1/en not_active IP Right Cessation
- 1994-04-26 EP EP00200859A patent/EP1005872B1/en not_active Expired - Lifetime
- 1994-04-26 DE DE69413395T patent/DE69413395T2/en not_active Expired - Lifetime
- 1994-04-26 DE DE69434462T patent/DE69434462T2/en not_active Expired - Lifetime
- 1994-04-26 JP JP7500438A patent/JP2836965B2/en not_active Expired - Lifetime
- 1994-04-26 WO PCT/IB1994/000083 patent/WO1994027651A1/en active IP Right Grant
- 1994-04-26 AT AT00200859T patent/ATE302032T1/en not_active IP Right Cessation
- 1994-04-26 EP EP94912052A patent/EP0701453B1/en not_active Expired - Lifetime
- 1994-04-26 EP EP05017610A patent/EP1598086A2/en not_active Withdrawn
- 1994-04-26 AT AT98103006T patent/ATE196095T1/en active
- 1994-04-26 AU AU64364/94A patent/AU684500B2/en not_active Ceased
- 1994-04-26 DE DE9490446U patent/DE9490446U1/en not_active Expired - Lifetime
- 1994-10-07 US US08/320,705 patent/US5449745A/en not_active Expired - Fee Related
-
1995
- 1995-03-15 US US08/404,663 patent/US5543471A/en not_active Expired - Lifetime
- 1995-05-11 US US08/439,028 patent/US5650485A/en not_active Expired - Lifetime
-
1996
- 1996-10-16 US US08/733,067 patent/US5728748A/en not_active Expired - Lifetime
-
1998
- 1998-01-23 US US09/012,345 patent/US6174934B1/en not_active Expired - Fee Related
-
2000
- 2000-06-28 US US09/604,868 patent/US6372814B1/en not_active Expired - Fee Related
-
2002
- 2002-01-08 US US10/041,118 patent/US6664308B2/en not_active Expired - Fee Related
-
2003
- 2003-06-13 US US10/461,636 patent/US6818020B2/en not_active Expired - Fee Related
-
2004
- 2004-09-07 US US10/935,510 patent/US20050059750A1/en not_active Abandoned
Patent Citations (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3330748A (en) * | 1955-01-11 | 1967-07-11 | Gen Electric | Method and apparatus for irradiating organic polymers with electrons |
US2904480A (en) * | 1955-06-06 | 1959-09-15 | Grace W R & Co | Polyethylene |
US3563869A (en) * | 1957-11-05 | 1971-02-16 | Grace W R & Co | Irradiated polyethylene |
US3022543A (en) * | 1958-02-07 | 1962-02-27 | Grace W R & Co | Method of producing film having improved shrink energy |
US3057791A (en) * | 1959-07-06 | 1962-10-09 | Phillips Petroleum Co | Radiation curing of polymers |
US3090770A (en) * | 1960-04-26 | 1963-05-21 | Grace W R & Co | Blended polyethylene compositions of improved clarity and method of making same |
US3162623A (en) * | 1961-12-26 | 1964-12-22 | Du Pont | Crosslinking of polymers with nitrogen fluorides |
US3362897A (en) * | 1962-11-21 | 1968-01-09 | Gen Electric | Stable irradiated polyethylene |
US3297641A (en) * | 1964-01-17 | 1967-01-10 | Grace W R & Co | Process for cross-linking polyethylene |
US3352818A (en) * | 1964-01-31 | 1967-11-14 | Glanzstoff Ag | Stability of polyolefines |
US3616365A (en) * | 1966-05-27 | 1971-10-26 | Basf Ag | Process of making particulate expanded olefin polymers having high thermal stability |
US3832827A (en) * | 1967-12-18 | 1974-09-03 | J Lemelson | Container forming and filling apparatus |
US3758273A (en) * | 1970-04-03 | 1973-09-11 | Gillette Co | Processes for sterilizing polypropylene objects |
US3886056A (en) * | 1971-11-01 | 1975-05-27 | Ryozo Kitamaru | Process for producing a high melting temperature polyethylene employing irradiation and orienting |
US4226905A (en) * | 1978-04-18 | 1980-10-07 | Du Pont Canada Inc. | Manufacture of film from partially crosslinked polyethylene |
US5160464A (en) * | 1983-12-09 | 1992-11-03 | National Research Development Corporation | Polymer irradiation |
US4587163A (en) * | 1984-03-06 | 1986-05-06 | Zachariades Anagnostis E | Preparation of ultra high molecular weight polyethylene morphologies of totally fused particles with superior mechanical performance |
US4587163B1 (en) * | 1984-03-06 | 1990-04-03 | E Zachariades Anagnostis | |
US4655769A (en) * | 1984-10-24 | 1987-04-07 | Zachariades Anagnostis E | Ultra-high-molecular-weight polyethylene products including vascular prosthesis devices and methods relating thereto and employing pseudo-gel states |
US4820466A (en) * | 1985-01-31 | 1989-04-11 | Zachariades Anagnostis E | Process for obtaining ultra-high modulus products |
US4950151A (en) * | 1985-01-31 | 1990-08-21 | Zachariades Anagnostic E | Rolling die for producing high modulus products |
US4832965A (en) * | 1985-05-17 | 1989-05-23 | Helin Stig Aake | Method of making a bottle and packaging a water ration therein |
US4701288A (en) * | 1985-06-05 | 1987-10-20 | Bausch & Lomb Incorporated | Method of making articles of dissimilar polymer compositions |
US4813210A (en) * | 1985-09-27 | 1989-03-21 | Nissho Corporation | Radiation-sterilized, packaged medical device |
US5096654A (en) * | 1987-07-24 | 1992-03-17 | The National Research And Development Corporation | Solid phase deformation process |
US5047446A (en) * | 1988-07-22 | 1991-09-10 | Himont Incorporated | Thermal treatment of irradiated propylene polymer material |
US5030402A (en) * | 1989-03-17 | 1991-07-09 | Zachariades Anagnostis E | Process for producing a new class of ultra-high-molecular-weight polyethylene orthopaedic prostheses with enhanced mechanical properties |
US5037928A (en) * | 1989-10-24 | 1991-08-06 | E. I. Du Pont De Nemours And Company | Process of manufacturing ultrahigh molecular weight linear polyethylene shaped articles |
US5160677A (en) * | 1989-12-15 | 1992-11-03 | United States Surgical Corporation | Pressurized powder support for treating processes |
US5153039A (en) * | 1990-03-20 | 1992-10-06 | Paxon Polymer Company, L.P. | High density polyethylene article with oxygen barrier properties |
US5200439A (en) * | 1990-04-13 | 1993-04-06 | Mitsui Toatsu Chemicals, Inc. | Method for increasing intrinsic viscosity of syndiotactic polypropylene |
US5428079A (en) * | 1990-08-01 | 1995-06-27 | Dsm N.V. | Solution of ultra-high molecular weight polyethylene |
US5352732A (en) * | 1990-08-07 | 1994-10-04 | E. I. Du Pont De Nemours And Company | Homogeneous, high modulus ultrahigh molecular weight polyethylene composites and processes for the preparation thereof |
US5552104A (en) * | 1991-06-21 | 1996-09-03 | Montell North America Inc. | High melt strength, ethylene polymer, process for making it, and use thereof |
US5508319A (en) * | 1991-06-21 | 1996-04-16 | Montell North America Inc. | High melt strength, ethylene polymer, process for making it, and use thereof |
US5466530A (en) * | 1993-01-21 | 1995-11-14 | England; Garry L. | Biocompatible components fabricated from a substantially consolidated stock of material |
US6174934B1 (en) * | 1993-06-01 | 2001-01-16 | Stryker Technologies Corporation | Non-oxidizing polymeric medical implant |
US5728748A (en) * | 1993-06-01 | 1998-03-17 | Howmedica Inc. | Non oxidizing polymeric medical implant |
US20020107299A1 (en) * | 1993-06-01 | 2002-08-08 | Deh-Chuan Sun | Non-oxidizing polymeric medical implant |
US6664308B2 (en) * | 1993-06-01 | 2003-12-16 | Stryker Technologies Corporation | Non-oxidizing polymeric medical implant |
US6818020B2 (en) * | 1993-06-01 | 2004-11-16 | Howmedica Osteonics Corp. | Non-oxidizing polymeric medical implant |
US5543471A (en) * | 1993-06-01 | 1996-08-06 | Howmedica Inc. | Non-oxidizing polymeric medical implant |
US6168626B1 (en) * | 1994-09-21 | 2001-01-02 | Bmg Incorporated | Ultra high molecular weight polyethylene molded article for artificial joints and method of preparing the same |
US6281264B1 (en) * | 1995-01-20 | 2001-08-28 | The Orthopaedic Hospital | Chemically crosslinked ultrahigh molecular weight polyethylene for artificial human joints |
US5577368A (en) * | 1995-04-03 | 1996-11-26 | Johnson & Johnson Professional, Inc. | Method for improving wear resistance of polymeric bioimplantable components |
US5879400A (en) * | 1996-02-13 | 1999-03-09 | Massachusetts Institute Of Technology | Melt-irradiated ultra high molecular weight polyethylene prosthetic devices |
US6641617B1 (en) * | 1996-02-13 | 2003-11-04 | The General Hospital Corp. | Radiation and melt treated ultra high molecular weight polyethylene prosthetic device and method |
US5753182A (en) * | 1996-02-14 | 1998-05-19 | Biomet, Inc. | Method for reducing the number of free radicals present in ultrahigh molecular weight polyethylene orthopedic components |
US6228900B1 (en) * | 1996-07-09 | 2001-05-08 | The Orthopaedic Hospital And University Of Southern California | Crosslinking of polyethylene for low wear using radiation and thermal treatments |
US6017975A (en) * | 1996-10-02 | 2000-01-25 | Saum; Kenneth Ashley | Process for medical implant of cross-linked ultrahigh molecular weight polyethylene having improved balance of wear properties and oxidation resistance |
US6562540B2 (en) * | 1996-10-02 | 2003-05-13 | Depuy Orthopaedics, Inc. | Process for medical implant of cross-linked ultrahigh molecular weight polyethylene having improved balance of wear properties and oxidation resistance |
US6494917B1 (en) * | 1996-10-15 | 2002-12-17 | Orthopaedic Hospital | Wear resistant surface-gradient crosslinked polyethylene |
US5874123A (en) * | 1997-01-24 | 1999-02-23 | Park; Joon B. | Precoated polymeric prosthesis and process for making same |
US6432349B1 (en) * | 1999-06-29 | 2002-08-13 | Zimmer, Inc. | Process of making an articulating bearing surface |
US6143232A (en) * | 1999-07-29 | 2000-11-07 | Bristol-Meyers Squibb Company | Method of manufacturing an articulating bearing surface for an orthopaedic implant |
US6184265B1 (en) * | 1999-07-29 | 2001-02-06 | Depuy Orthopaedics, Inc. | Low temperature pressure stabilization of implant component |
US6272814B1 (en) * | 1999-11-22 | 2001-08-14 | Wakai & Co., Ltd. | Method of packaging nut assemblies |
US20020013781A1 (en) * | 2000-01-13 | 2002-01-31 | Erik Petersen | System and method of searchin and gathering information on-line and off-line |
US6395799B1 (en) * | 2000-02-21 | 2002-05-28 | Smith & Nephew, Inc. | Electromagnetic and mechanical wave energy treatments of UHMWPE |
US6503439B1 (en) * | 2000-06-15 | 2003-01-07 | Albert H. Burstein | Process for forming shaped articles of ultra high molecular weight polyethylene suitable for use as a prosthetic device or a component thereof |
US6547828B2 (en) * | 2001-02-23 | 2003-04-15 | Smith & Nephew, Inc. | Cross-linked ultra-high molecular weight polyethylene for medical implant use |
Cited By (95)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE44762E1 (en) | 1994-09-21 | 2014-02-11 | Bmg Incorporated | Ultra high molecular weight polyethylene molded article for artificial joints and method of preparing the same |
US8865788B2 (en) | 1996-02-13 | 2014-10-21 | The General Hospital Corporation | Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices |
US7858671B2 (en) | 1996-02-13 | 2010-12-28 | The General Hospital Corporation | Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices |
US8563623B2 (en) | 1996-02-13 | 2013-10-22 | The General Hospital Corporation | Radiation melt treated ultra high molecular weight polyethylene prosthetic devices |
US8263676B2 (en) | 1996-02-13 | 2012-09-11 | The General Hospital Corporation | Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices |
US9492280B2 (en) | 2000-11-28 | 2016-11-15 | Medidea, Llc | Multiple-cam, posterior-stabilized knee prosthesis |
US10188521B2 (en) | 2000-11-28 | 2019-01-29 | Medidea, Llc | Multiple-cam, posterior-stabilized knee prosthesis |
US20100298945A1 (en) * | 2004-10-07 | 2010-11-25 | Biomet Manufacturing Corp. | Crosslinked polymeric material with enhanced strength and process for manufacturing |
US8398913B2 (en) | 2004-10-07 | 2013-03-19 | Biomet Manufacturing Corp. | Solid state deformation processing of crosslinked high molecular weight polymeric materials |
US7927536B2 (en) | 2004-10-07 | 2011-04-19 | Biomet Manufacturing Corp. | Solid state deformation processing of crosslinked high molecular weight polymeric materials |
US20060079595A1 (en) * | 2004-10-07 | 2006-04-13 | Schroeder David W | Solid state deformation processing of crosslinked high molecular weight polymeric materials |
US8137608B2 (en) | 2004-10-07 | 2012-03-20 | Biomet Manufacturing Corp. | Crosslinked polymeric material with enhanced strength and process for manufacturing |
US7993401B2 (en) | 2004-10-07 | 2011-08-09 | Biomet Manufacturing Corp. | Solid state deformation processing of crosslinked high molecular weight polymeric materials |
US20060079596A1 (en) * | 2004-10-07 | 2006-04-13 | Schroeder David W | Crosslinked polymeric material with enhanced strength and process for manufacturing |
US8262976B2 (en) | 2004-10-07 | 2012-09-11 | Biomet Manufacturing Corp. | Solid state deformation processing of crosslinked high molecular weight polymeric materials |
US9017590B2 (en) | 2004-10-07 | 2015-04-28 | Biomet Manufacturing, Llc | Solid state deformation processing of crosslinked high molecular weight polymeric materials |
US20100314800A1 (en) * | 2004-10-07 | 2010-12-16 | Biomet Manufacturing Corporation | Solid state deformation processing of crosslinked high molecular weight polymeric materials |
US20090082546A1 (en) * | 2004-10-07 | 2009-03-26 | Biomet Manufacturing Corp. | Crosslinked polymeric material with enhanced strength and process for manufacturing |
US7780896B2 (en) | 2004-10-07 | 2010-08-24 | Biomet Manufacturing Corp. | Crosslinked polymeric material with enhanced strength and process for manufacturing |
US20060280645A1 (en) * | 2005-06-02 | 2006-12-14 | Scott Sellers | Method for terminal sterilization of transdermal delivery devices |
US20060280644A1 (en) * | 2005-06-02 | 2006-12-14 | Scott Sellers | Method for terminal sterilization of transdermal delivery devices |
US20090212343A1 (en) * | 2005-06-15 | 2009-08-27 | Actel Corporation | Non-volatile two-transistor programmable logic cell and array layout |
US8673202B2 (en) | 2005-08-18 | 2014-03-18 | Zimmer, Gmbh | Ultra high molecular weight polyethylene articles and methods of forming ultra high molecular weight polyethylene articles |
US7863348B2 (en) | 2005-08-18 | 2011-01-04 | Zimmer Gmbh | Ultra high molecular weight polyethylene articles and methods of forming ultra high molecular weight polyethylene articles |
US11001680B2 (en) | 2005-08-18 | 2021-05-11 | Zimmer Gmbh | Ultra high molecular weight polyethylene articles and methods of forming ultra high molecular weight polyethylene articles |
US20110135917A1 (en) * | 2005-08-18 | 2011-06-09 | Zimmer Gmbh | Ultra High Molecular Weight Polyethylene Articles And Methods Of Forming Ultra High Molecular Weight Polyethylene Articles |
US20070059334A1 (en) * | 2005-08-18 | 2007-03-15 | Zimmer Technology, Inc. | Ultra high molecular weight polyethylene articles and methods of forming ultra high molecular weight polyethylene articles |
US8470903B2 (en) | 2005-08-18 | 2013-06-25 | Zimmer Gmbh | Ultra high molecular weight polyethylene articles and methods of forming ultra high molecular weight polyethylene articles |
US11015030B2 (en) | 2005-08-18 | 2021-05-25 | Zimmer Gmbh | Ultra high molecular weight polyethylene articles and methods of forming ultra high molecular weight polyethylene articles |
US20090118390A1 (en) * | 2005-08-18 | 2009-05-07 | Abt Niels A | Ultra high molecular weight polyethylene articles and methods of forming ultra high molecular weight polyethylene articles |
US7846376B2 (en) | 2005-08-18 | 2010-12-07 | Zimmer Gmbh | Ultra high molecular weight polyethylene articles and methods of forming ultra high molecular weight polyethylene articles |
US8178594B2 (en) | 2007-04-10 | 2012-05-15 | Zimmer, Inc. | Antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications |
US8669299B2 (en) | 2007-04-10 | 2014-03-11 | Zimmer, Inc. | Antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications |
US9926432B2 (en) | 2007-04-10 | 2018-03-27 | Zimmer, Inc. | Antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications |
US9265545B2 (en) | 2007-04-10 | 2016-02-23 | Zimmer, Inc. | Antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications |
US10556998B2 (en) | 2007-04-10 | 2020-02-11 | Zimmer, Inc. | Antioxidant stabilized crosslinked ultra high molecular weight polyethylene for medical device applications |
US20110028600A1 (en) * | 2007-04-10 | 2011-02-03 | Zimmer, Inc. | Antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications |
US9822224B2 (en) | 2007-04-10 | 2017-11-21 | Zimmer, Inc. | Antioxidant stabilized crosslinked ultra high molecular weight polyethylene for medical device applications |
US8129440B2 (en) * | 2007-04-10 | 2012-03-06 | Zimmer, Inc. | Antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications |
US20100029858A1 (en) * | 2007-04-10 | 2010-02-04 | Zimmer, Inc. | Antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications |
US20110133371A1 (en) * | 2007-04-10 | 2011-06-09 | Zimmer, Inc. | Antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications |
US8664290B2 (en) | 2007-04-10 | 2014-03-04 | Zimmer, Inc. | Antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications |
US9277949B2 (en) | 2007-04-10 | 2016-03-08 | Zimmer, Inc. | Antioxidant stabilized crosslinked ultra high molecular weight polyethylene for medical device applications |
US8641959B2 (en) | 2007-07-27 | 2014-02-04 | Biomet Manufacturing, Llc | Antioxidant doping of crosslinked polymers to form non-eluting bearing components |
US20090030524A1 (en) * | 2007-07-27 | 2009-01-29 | Biomet Manufacturing Corp. | Antioxidant doping of crosslinked polymers to form non-eluting bearing components |
US9421104B2 (en) | 2007-07-27 | 2016-08-23 | Biomet Manufacturing, Llc | Antioxidant doping of crosslinked polymers to form non-eluting bearing components |
US9398956B2 (en) | 2007-09-25 | 2016-07-26 | Depuy (Ireland) | Fixed-bearing knee prosthesis having interchangeable components |
US9204967B2 (en) | 2007-09-28 | 2015-12-08 | Depuy (Ireland) | Fixed-bearing knee prosthesis having interchangeable components |
US8128703B2 (en) | 2007-09-28 | 2012-03-06 | Depuy Products, Inc. | Fixed-bearing knee prosthesis having interchangeable components |
US10118998B2 (en) * | 2007-11-06 | 2018-11-06 | Dsm Ip Assets B.V. | Process for producing high molecular weight polyethylene |
US9555160B2 (en) * | 2007-11-06 | 2017-01-31 | Dsm Ip Assets B.V. | Process for producing high molecular weight polyethylene |
WO2009060043A2 (en) * | 2007-11-06 | 2009-05-14 | Dsm Ip Assets Bv | Process for producing high molecular weight polyethylene |
US9238719B2 (en) * | 2007-11-06 | 2016-01-19 | Dsm Ip Assets B.V. | Process for producing high molecular weight polyethylene |
US20150203641A1 (en) * | 2007-11-06 | 2015-07-23 | Dsm Ip Assets B.V. | Process for producing high molecular weight polyethylene |
US20160184476A1 (en) * | 2007-11-06 | 2016-06-30 | Dsm Ip Assets B.V. | Process for producing high molecular weight polyethylene |
US9290629B2 (en) * | 2007-11-06 | 2016-03-22 | Dsm Ip Assets B.V. | Process for producing high molecular weight polyethylene |
WO2009060043A3 (en) * | 2007-11-06 | 2009-08-27 | Dsm Ip Assets Bv | Process for producing high molecular weight polyethylene |
US20100331995A1 (en) * | 2007-11-06 | 2010-12-30 | Harold Jan Smelt | Process for producing high molecular weight polyethylene |
US9718241B2 (en) | 2008-01-30 | 2017-08-01 | Zimmer, Inc. | Method of manufacturing an acetabular component |
US8652212B2 (en) | 2008-01-30 | 2014-02-18 | Zimmer, Inc. | Orthopedic component of low stiffness |
US8734522B2 (en) | 2008-06-30 | 2014-05-27 | Depuy (Ireland) | Posterior stabilized orthopaedic prosthesis |
US8236061B2 (en) | 2008-06-30 | 2012-08-07 | Depuy Products, Inc. | Orthopaedic knee prosthesis having controlled condylar curvature |
US9204968B2 (en) | 2008-06-30 | 2015-12-08 | Depuy (Ireland) | Posterior stabilized orthopaedic prosthesis |
US9168145B2 (en) | 2008-06-30 | 2015-10-27 | Depuy (Ireland) | Posterior stabilized orthopaedic knee prosthesis having controlled condylar curvature |
US9326864B2 (en) | 2008-06-30 | 2016-05-03 | Depuy (Ireland) | Orthopaedic knee prosthesis having controlled condylar curvature |
US9119723B2 (en) | 2008-06-30 | 2015-09-01 | Depuy (Ireland) | Posterior stabilized orthopaedic prosthesis assembly |
US11730602B2 (en) | 2008-06-30 | 2023-08-22 | Depuy Ireland Unlimited Company | Orthopaedic knee prosthesis having controlled condylar curvature |
US8834575B2 (en) | 2008-06-30 | 2014-09-16 | Depuy (Ireland) | Posterior stabilized orthopaedic knee prosthesis having controlled condylar curvature |
US9452053B2 (en) | 2008-06-30 | 2016-09-27 | Depuy (Ireland) | Orthopaedic knee prosthesis having controlled condylar curvature |
US8828086B2 (en) | 2008-06-30 | 2014-09-09 | Depuy (Ireland) | Orthopaedic femoral component having controlled condylar curvature |
US9539099B2 (en) | 2008-06-30 | 2017-01-10 | Depuy Ireland Unlimited Company | Orthopaedic knee prosthesis having controlled condylar curvature |
US8795380B2 (en) | 2008-06-30 | 2014-08-05 | Depuy (Ireland) | Orthopaedic knee prosthesis having controlled condylar curvature |
US11369478B2 (en) | 2008-06-30 | 2022-06-28 | Depuy Ireland Unlimited Company | Orthopaedic knee prosthesis having controlled condylar curvature |
US11337823B2 (en) | 2008-06-30 | 2022-05-24 | Depuy Ireland Unlimited Company | Orthopaedic femoral component having controlled condylar curvature |
US8784496B2 (en) | 2008-06-30 | 2014-07-22 | Depuy (Ireland) | Orthopaedic knee prosthesis having controlled condylar curvature |
US10849760B2 (en) | 2008-06-30 | 2020-12-01 | Depuy Ireland Unlimited Company | Orthopaedic knee prosthesis having controlled condylar curvature |
US10729551B2 (en) | 2008-06-30 | 2020-08-04 | Depuy Ireland Unlimited Company | Orthopaedic knee prosthesis having controlled condylar curvature |
US9220601B2 (en) | 2008-06-30 | 2015-12-29 | Depuy (Ireland) | Orthopaedic femoral component having controlled condylar curvature |
US9931216B2 (en) | 2008-06-30 | 2018-04-03 | Depuy Ireland Unlimited Company | Orthopaedic femoral component having controlled condylar curvature |
US9937049B2 (en) | 2008-06-30 | 2018-04-10 | Depuy Ireland Unlimited Company | Orthopaedic knee prosthesis having controlled condylar curvature |
US8206451B2 (en) | 2008-06-30 | 2012-06-26 | Depuy Products, Inc. | Posterior stabilized orthopaedic prosthesis |
US10179051B2 (en) | 2008-06-30 | 2019-01-15 | Depuy Ireland Unlimited Company | Orthopaedic knee prosthesis having controlled condylar curvature |
US8187335B2 (en) | 2008-06-30 | 2012-05-29 | Depuy Products, Inc. | Posterior stabilized orthopaedic knee prosthesis having controlled condylar curvature |
US8192498B2 (en) | 2008-06-30 | 2012-06-05 | Depuy Products, Inc. | Posterior cructiate-retaining orthopaedic knee prosthesis having controlled condylar curvature |
US10265180B2 (en) | 2008-06-30 | 2019-04-23 | Depuy Ireland Unlimited Company | Orthopaedic knee prosthesis having controlled condylar curvature |
US10543098B2 (en) | 2008-06-30 | 2020-01-28 | Depuy Ireland Unlimited Company | Orthopaedic femoral component having controlled condylar curvature |
US9745462B2 (en) | 2008-11-20 | 2017-08-29 | Zimmer Gmbh | Polyethylene materials |
US20100137481A1 (en) * | 2008-11-20 | 2010-06-03 | Zimmer Gmbh | Polyethylene materials |
US20110178605A1 (en) * | 2010-01-21 | 2011-07-21 | Depuy Products, Inc. | Knee prosthesis system |
US9011547B2 (en) | 2010-01-21 | 2015-04-21 | Depuy (Ireland) | Knee prosthesis system |
US8399535B2 (en) | 2010-06-10 | 2013-03-19 | Zimmer, Inc. | Polymer [[s]] compositions including an antioxidant |
US9586370B2 (en) | 2013-08-15 | 2017-03-07 | Biomet Manufacturing, Llc | Method for making ultra high molecular weight polyethylene |
US9708467B2 (en) | 2013-10-01 | 2017-07-18 | Zimmer, Inc. | Polymer compositions comprising one or more protected antioxidants |
US10184031B2 (en) | 2014-03-12 | 2019-01-22 | Zimmer, Inc. | Melt-stabilized ultra high molecular weight polyethylene and method of making the same |
US10265891B2 (en) | 2014-12-03 | 2019-04-23 | Zimmer, Inc. | Antioxidant-infused ultra high molecular weight polyethylene |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6818020B2 (en) | Non-oxidizing polymeric medical implant | |
US9650476B2 (en) | Sequentially cross-linked polyethylene | |
US20130064711A1 (en) | Polyethylene cross-linked with an anthocyanin | |
EP2921186B1 (en) | Annealing method for cross-linked polyethylene |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: HOWMEDICA OSTEONICS CORP., NEW JERSEY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SUN, DEH-CHUAN;STARK, CASPER F.;REEL/FRAME:015391/0613;SIGNING DATES FROM 20041107 TO 20041112 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- AFTER EXAMINER'S ANSWER OR BOARD OF APPEALS DECISION |